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Abstract
Obesity affects more than 30 percent of the worldwide population reaching pandemic
dimensions. Furthermore, obesity is associated with the development of metabolic dis-
orders, such as insulin resistance that is at least partly caused by an increased inflamma-
tory state. The chronic low-grade inflammation under obese conditions induces stress
signaling pathways such as c-Jun N-terminal kinase (JNK) and endoplasmic reticulum
stress leading to the activation of the X-box binding protein 1 (XBP1), both might con-
tribute to the development of obesity-associated insulin resistance. While recent studies
using whole body JNK-1 knockout mice have implicated a crucial role for stress signaling
induced JNK-1 in the development of obesity-associated insulin resistance, neither the
metabolic tissue in which JNK-1 ablation sensitizes for insulin action nor the cell type-
specific function of the other JNK isoform JNK-2 could be identified in these studies.
To this end, mouse models carrying skeletal muscle specific inactivation or constant acti-
vation of JNK-1 were analysed for alterations in energy and glucose homeostasis. While
mice with a skeletal muscle specific JNK-1 deficiency or constitutive activation of JNK-1
demonstrated largely unaltered body weight gain, glucose tolerance and insulin sensitiv-
ity, JNK-1 was responsible to induce exercise-dependent increases of the myokine IL-6 in
skeletal muscle. These data reveal a novel role for stress-induced JNK-1 in skeletal mus-
cle in the context of physical activity, controlling the beneficial effects of IL-6 in response
to exercise. Moreover, a conditional JNK-2 mouse line was created in this study allowing
for the cell type-specific inactivation of JNK-2 in tissues that express the Cre recombinase.
Furthermore, mice were generated that carry a conditional allele of the spliced and tran-
scriptionally active form of the murine XBP1 (mXBP1s) to mimic ER stress that is as-
sociated with obesity. These mice were crossed with CAMKII-Cre and ALFP-Cre mice
that resulted in mXBP1s expression and the induction of ER stress in hippocampus and
liver, respectively. Surprisingly, however, qPCR analysis indicated that the central ex-
pression of mXBP1s resulted not only in the neuron-specific induction of ER stress, but
also revealed upregulated CHOP and GRP78 expression in liver, implicating a crosstalk
between brain and liver in the transmission of ER stress.
Also, the novel FABP4-2A-Cre mouse line was characterized using ROSA26-FOXODN
and IL-6RαFL mice as reporter alleles. While FABP4-2A-Cre excised the loxP-flanked
STOP sequence of ROSA26-FOXODN mice exclusively in WAT, BAT and myeloid lineage
cell types, the loxP-flanked exons of the IL-6Rα gene were completely excised indicating
the occurence of a transient FABP4 expression early during embryonic development.
Collectively, the herein generated mouse lines will be valuable tools for further studies
addressing the cell type-specific role of stress signaling pathways in metabolic disorders.
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Zusammenfassung
Adipositas breitet sich weltweit aus und betrifft mittlerweile 30 Prozent der globalen
Bevölkerung. Zudem ist Fettleibigkeit mit einem erhöhten Risiko verbunden, Stoffwech-
selkrankheiten zu begünstigen wie die Entstehung einer Insulin-Resistenz. Die Insulin-
Resistenz wird teils durch verstärkt auftretende Entzündungsprozesse bei Adipositas
verursacht, die zur Aktivierung von Stress-Signal-Wegen führen, z.B. dem c-Jun N- ter-
minalen Kinase (JNK) Signalweg oder erhöhtem Stress im endoplasmatischen Reticu-
lum (ER), welcher in der Aktivierung des X-box bindenden Protein 1 (XBP1) resultiert.
Jüngste Studien, in denen JNK-1 im ganzen Körper inaktiviert wurde, weisen daraufhin,
dass JNK-1 eine zentrale Rolle bei der Entstehung der Adipositas-assoziierten Insulin-
Resistenz einnimmt. Allerdings konnten diese Studien weder das Gewebe identifizieren,
in welchem eine JNK-1 Inaktivierung die Insulin Wirkung sensibilisiert, noch konnte
die Zelltyp-spezifische Rolle von JNK-2 aufgeklärt werden. Daher wurden in dieser
Arbeit Maus-Modelle generiert, in denen JNK-1 spezifisch im Skelettmuskel inaktiviert
oder konstant aktiviert wurde. Während diese Mausmutanten im Vergleich zu Wildtyp-
Mäusen eine unveränderte Gewichtszunahme, sowie eine mit Wildtyp-Mäusen vergle-
ichbare Glukosetoleranz und Insulinsensitivität zeigten, so konnte nachgewiesen wer-
den, dass JNK-1 für die Sekretion des Myokins Interleukin 6 (IL-6) im Skelettmuskel
während körperlicher Aktivität verantwortlich ist. Diese Erkenntnis belegt eine neue
Rolle des Stress-induzierbaren JNK-1 Proteins während körperlicher Anstrengung, da
es die vorteilhaften Effekte von IL-6 als Antwort auf diese Aktivität kontrolliert. Zusät-
zlich wurde eine konditionale JNK-2 Maus-Linie generiert, die es erlaubt JNK-2 in Or-
ganen zu inaktivieren, in denen die Cre-Rekombinase exprimiert wird. Weiterhin wur-
den Mäuse erzeugt, die ein induzierbares Allel des gespleißten und transkriptionell ak-
tiven murinen XBP1 Proteins (mXBP1s) in ihrem Genom tragen. Das Kreuzen dieser
mit Mäusen, welche die CAMKII-Cre oder die ALFP-Cre exprimieren, resultierte in der
Expression von mXBP1s und der Induktion von ER Stress im Hippocampus bzw. der
Leber. Überraschenderweise deutete eine Analyse mittels qPCR daraufhin, dass die
zentrale Expression von mXBP1s nicht nur in neuronalen ER Stress resultiert, sondern
es wurden auch erhöhte Expressionswerte von CHOP und GRP78 in der Leber dieser
Tiere festgestellt. Dies deutet auf eine Verbindung zwischen Gehirn und Leber in Bezug
auf die Weiterleitung des ER Stresses hin. Ferner wurde die neu-entwickelte FABP4-
2A-Cre Maus-Linie charakterisiert. Mit ROSA26-FOXODN und IL-6RαFL Mäusen als
Reporter, konnte gezeigt werden, dass die loxP-flankierte STOP-Sequenz der ROSA26-
FOXODN Mäuse exklusiv im weißen und braunen Fettgewebe und in Makrophagen
durch die Aktivität der FABP4-2A-Cre herausgeschnitten wurde. Allerdings wurden die
loxP-flankierten Exons des IL-6Rα Gens komplett deletiert. Dies legt nahe, dass FABP4
bereits früh während der Embryonalentwicklung transient exprimiert wird. Insgesamt
stellen die hier präsentierten Maus-Linien ein verlässliches und nützliches Werkzeug dar,
um in zukünftigen Studien die Zelltyp-spezifische Rolle von Stress-Signalwegen bei Stof-
fwechselkrankheiten zu untersuchen.
xiii
1 Introduction
1.1 Metabolic Homeostasis
Individuals are able to maintain a steady body weight. This tightly regulated process
is dependent on compensatory signals which sense high and low energy states of the
body (Schwartz, 2004, 2006). Malfunctions in this regulatory system lead towards in-
creased energy storage, body weight gain and may eventuate in obesity. These failures in
metabolic regulation are induced by environmental factors or by genetic predisposition,
or the combination of both. Energy-dense food, new dietary compounds, an increased
life span and insufficient physical activity all challenge the regulatory systems to main-
tain this homeostasis (Hill & Peters, 1998; Hill et al. , 2003). Studies have investigated
how certain genetic factors influence this homeostasis. Mutations in the hormone leptin,
which is secreted by the adipose tissue to reduce food intake and enhance physical ac-
tivity, have been identified in obese patients (Barsh et al. , 2000). Moreover, the fat mass
and obesity associated (FTO) gene was identified, which predisposes its carrier to the
development of obesity (Fischer et al. , 2009; Frayling et al. , 2007). The "thrifty gene"
hypothesis, which describes the evolutionary benefits of genes promoting high energy
storage is now needless in developed societies where there is perpetual availability of
energy dense foods (Sharma, 1998).
Understanding the regulation of metabolic balance is of crucial importance in preventing
the development of obesity.
1.2 Obesity and Type 2 Diabetes - Metabolic Threats
Formerly obesity was described as a disease affecting well-developed and wealthy coun-
tries, possessing an overabundance of food and well established transportation systems
(Mokdad et al. , 2003). However, now obesity is also prevalent in less well developed
countries, leading to epidemic proportions. Estimations by the world health organiza-
tion (WHO) reveal that in 2008, 1.5 billion adults were overweight, and among these 500
million people were obese. In Germany 61 % people were estimated to be overweight,
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and 25 % of these obese (WHO, 2008). Furthermore, childhood obesity is steadily increas-
ing, with 43 million children under the age of five years worldwide being overweight
(WHO). This is a very worrying trend, since these children are predisposed to develop
obesity later in life. Crucially, the obesity pandemic places a huge burden on health care
expenditure (Pedersen, 2011). Currently, the WHO defines obesity and overweight on
measures of the body mass index (BMI). The BMI is the measurement of the person’s
weight in kilograms divided by the square of his height in meters (kg/m2). A BMI equal
or greater than 25 defines overweight and a BMI equal or greater than 30 characterizes
obesity (WHO).
Interestingly, the drastic increase in obesity is accompanied by a worldwide rise in phys-
ical inactivity. Indeed, the prevalence of obesity and the rate of physical inactivity are
closely related (Fig. 1.1).
A B
0-20 % 20-30 % > 30 % 0-30 % 30-50 % > 50 %
Figure 1.1: Obesity and physical inactivity are closely related.
Map of global distribution of (A) obesity and (B) physical inactivity. Colors indicate prevalence of
obesity or physical inactivity in the respective countries. (grey = no data available; adapted from
WHO)
30 % of the german population are physical inactive, which is associated with prema-
ture death (WHO), and a shortened life span of on average five years compared to that
of physically active people (Pedersen, 2011).
Obesity is characterized by an excess accumulation of fat due to an imbalance in metabolic
homeostasis and is linked to several disorders, including type 2 diabetes, cardiovascular
disease, hypertension, arthritis, depression, and some forms of cancer (Pedersen, 2011).
Indeed, type 2 diabetes constitutes a large portion of the obesity induced health conse-
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quences (Zimmet et al. , 2001). Concomitantly with an increased prevalence of obesity 366
million people worldwide are projected to suffer from type 2 diabetes by the year 2030
(Wild et al. , 2004). A hallmark of type 2 diabetes is hyperglycemia and hyperinsulinemia,
however, this endocrine disorder differs from the juvenile type 1 diabetes. In type 1 di-
abtes insulin producing β-cells in the pancreatic islets of Langerhans in the pancreas are
destroyed by T-lymphocytes. This leads to a complete ablation of insulin secretion and is
denoted as an autoimmune disease (Eisenbarth et al. , 1988). Type 2 diabetes, is described
as an adult-onset disease, however in recent years there is an increased appearance of
type 2 diabetes in younger adults (Saltiel & Kahn, 2001). Type 2 diabetes is characterized
by an inability to respond appropriately to insulin (Kahn et al. , 1996). This inability to
respond to insulin is also referred to as insulin resistance, and is induced by multiple
mechanisms influenced by both genetic and environmental factors (Chan et al. , 1994).
Huge efforts are being made to elucidate the underlying signaling pathways, and hence,
to understand the development of obesity and its associated metabolic disorders.
1.3 Insulin - the Metabolism’s Central Hormone
Frederick Grant Banting discovered insulin in 1921 as a substance to treat type 1 diabetes
(Banting et al. , 1962; Majumdar, 2001). Insulin is a hormone produced in pancreatic β-
cells and has several anabolic effects such as promoting glucose uptake and inhibiting
gluconeogenesis and lipolysis (Kahn et al. , 1996; Saltiel & Kahn, 2001). In healthy indi-
viduals insulin mediates these pleiotropic effects by binding to its receptor, which results
in a conformational change of the regulatory α-subunits and subsequent phosphorylation
of the catalytic β-subunits (Kasuga et al. , 1982; Patti & Kahn, 1998). The active insulin
receptor recruits and tyrosine phosphorylates proteins of the insulin-receptor-substrate
(IRS) family. (Isakoff et al. , 1996; Myers et al. , 1995). These molecules serve as a docking
platform for Src-homology (SH)-2 domain-containing proteins, such as the phosphatidyl-
inositol 3 (PI3)-kinase (Myers et al. , 1992, 1993) or growth factor receptor binding protein
(Grb)-2. Grb-2 initiates the Ras/Raf-mitogen activated protein kinase (MAPK)-pathway,
which has no role in transmitting the metabolic effects of insulin, but lead to cellular pro-
liferation and differentiation (Chang & Karin, 2001; White, 2003).
3
1 Introduction
The activation of the PI3-kinase pathway catalyzes the phosphorylation of phosphatidyli-
nositol (4,5) bisphosphate (PIP2) to phosphatidylinositol (3,4,5) triphosphate (PIP3) (Whit-
man et al. , 1988). These lipids have a high affinity for the PH-domain of the protein kinase
B (PKB, also known as AKT). PIP3 mediates the translocation of AKT to the cell mem-
brane, and AKT, in turn, co-localizes with phosphoinsositide-dependent protein kinase
1 (PDK-1) (Vanhaesebroeck & Alessi, 2000). This leads to a conformational change en-
abling PDK-1 to activate AKT by phosphorylation. The activation cascade downstream
of AKT leads to the metabolic effects of insulin, including expression of genes respon-
sible for glucose uptake, stimulation of glycogen and lipid synthesis, and inhibition of
gluconeogenesis and lipolysis (Cheatham & Kahn, 1995) (Fig. 1.2).
extracellular!
intracellular!
IRS-1!
PI3K!
AKT!
PDK-1!
PIP2!
PIP3!
Grb-2! Ras/Raf!
MAPK!
Insulin!
p85!p110!
p 
p 
p 
p p 
!"
#" IR!
PTEN!
PI3K!
Glycogen/lipid synthesis!Glucose transport!
Gene transcription!
Gene transcription!
Figure 1.2: Schematic view of the insulin signaling pathway.
Binding of insulin to its receptor activates the tyrosine kinase activity. The β-subunit of the recep-
tor is phosphorylated on three intracellular tyrosine residues, which enables the receptor to recruit
and phosphorylate IRS-proteins. IRS proteins serve as a docking platform for both the p85 and
p110 subunits of the PI3-kinase and the Grb-2 molecules, the latter induces the MAPK-signaling
pathway. Signaling via the PI3-kinase converts PIP2 into PIP3, which leads to recruitment of AKT
to the cell membrane via PDK-1 molecules, which further stimulate AKT activation. AKT, in
turn, implements the pleiotropic metabolic effects of insulin such as glucose uptake, or inhibition
of gluconeogenesis and lipolysis.
In obese individuals this insulin signaling cascade is disturbed (Prager et al. , 1987;
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White, 2003). However, the underlying signaling pathways contributing to this distur-
bance are not fully understood.
1.4 Obesity induced Stress-Kinase Signaling
In 1993, a first evidence for a link between obesity and inflammatory signaling was es-
tablished when Hotamisligil revealed increased expression of the tumor necrosis factor-α
(TNF-α) in adipose tissue of obese mice (Hotamisligil et al. , 1993; Uysal et al. , 1997).
Today, the link between obesity and inflammation is well established, but the precise
underlying mechanisms remain to be elucidated (Solinas & Karin, 2010). Obesity is as-
sociated with low grade chronic inflammation, reflected by immune cell invasion into
the adipose tissue. The first invading cells are T-cells, which further recruit non-resident
macrophages (Lumeng et al. , 2009). In combination with resident macrophages they re-
lease pro-inflammatory cytokines, which lead to the activation of inflammatory signaling
pathways in the adipose tissue and systemically in other metabolic tissues. This effect is
further aggravated by the leakage of fat molecules from expanded adipocytes (Feuerer
et al. , 2009). Indeed, the inhibtion of insulin signaling in obesity and type 2 diabetes is
largely caused by activation of two stress-sensitive kinases, namely the I κ B kinase (IKK)
and the c-Jun N-terminal kinase (JNK), both of which are activated by TNF-α and inter-
fere with insulin signaling (Arkan et al. , 2005; Solinas & Karin, 2010).
IKK phosphorylation is essential for the activation of the transcription factor nuclear fac-
tor κ light chain enhancer of activated B-cells (NFκB). Under normal conditions, NFκB is
bound in a complex to the inhibitor of IKK (IκB) (Courtois & Israël, 2011). Upon certain
stress-stimuli, such as UV-light, irradiation or cytokines like TNF-α, IκB is phosphory-
lated by IKK (Jimi & Ghosh, 2005). This phosphorylation of IκB leads to its proteasomal
degradation, and released NFκB can translocate into the nucleus to activate transcription
of diverse genes, such as IL-6 or IL-1β (Courtois & Israël, 2011). Strikingly, mice with an
increased hepatic activation of NFκB signaling develop both hepatic and systemic insulin
resistance (D Cai, 2005).
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1.4.1 Obesity induced JNK Activation
The JNK protein family was identified in 1993 as two protein kinases, p46JNK1 and
p54JNK2, phosphorylating the transcription factor c-Jun on the N-terminal Ser63 and
Ser73 residues (Hibi et al. , 1993). Presently it is established that the JNK family com-
prises three genes, resulting in three proteins, namely JNK-1, JNK-2, and JNK-3 (Weston
& Davis, 2007). In addition, several isoforms of JNK proteins resulting from alternative
splicing, have been described (Davis, 2000). JNKs are serine/threonine kinases belong-
ing to the mitogen-activated protein kinases (MAPK)-family, and thus are activated in a
MAPK-module upon certain stimuli such as UV-light (Davis, 2000). Two upstream MAP2
kinase kinases (MKK) have been described to activate JNK, namely MKK4 and MKK7.
Both phosphorylate JNK within a Thr-X-Tyr motif, with MKK4 preferring the Tyr185 site,
and MKK7 the Thr183 site (Davis, 2000). These differential phosphorylation sites provide
a molecular basis for the activation of JNK by various stimuli. MKK4 was shown to be
activated by environmental stress and MKK7 primarily by cytokines (Tournier et al. ,
2001). In addition, MKK7 was shown to solely phosphorylate JNK, whereas MKK4 also
phosphorylates the MAPK p38 (Tournier et al. , 1999). Moreover, the activation of JNK is
dependent on the JNK interacting protein 1 (JIP1), which ensures the local proximity of
the MAP kinase module (Jaeschke et al. , 2004).
JNK activation then leads to induction of transcription factor activator protein 1 (AP1),
which in turn leads to target gene expression.
Examination of the role of JNK in insulin-secreting cells in the pancreas revealed differ-
ential activity between the protein isoforms. While one study claimed that only JNK-1
and JNK-2 are expressed in pancreatic islets (Varona-Santos et al. , 2008), another study
also showed the expression of JNK-3 (Abdelli et al. , 2009). In the latter study, JNK-3 was
attributed a protective function on β-cell mass, whereas JNK-1 and JNK-2 lead to cell
death (Varona-Santos et al. , 2008).
JNK is drastically activated during obesity (Hirosumi et al. , 2002). In obesity, levels of
extracellular long-chain saturated free fatty acids are elevated (Weisberg et al. , 2003),
which is thought to activate JNK signaling via Toll-like receptor (TLR)-signaling path-
ways (Sabio & Davis, 2010) (Fig. 1.3). Moreover, obesity-induced inflammation and
increased TNF-α levels, also results in JNK activation (Sabio & Davis, 2010). Further-
more, obesity-induced ER stress is directly linked to JNK activation via the IRE1/XBP1-
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pathway (Urano et al. , 2000), and indirectly by increasing the amount of oxidative stress,
and accumulation of reactive oxygen species (ROS), such as O2- radicals or H2O2. ROS,
which also arise during oxidative phosphorylation in mitochondria, are known to acti-
vate the JNK pathway (Bouloumie et al. , 1999), presumably via activation of the apoptosis
signal-regulating kinase 1 (ASK1) (Ichijo et al. , 1997; Tobiume et al. , 2001) (Fig. 1.3).
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Figure 1.3: Obesity induced JNK activation leads to inhibition of the insulin signaling cascade.
Obesity leads to the activation of JNK by various inducers. Obesity increases the amount of
free saturated fatty acids leading to TLR-mediated JNK activation. In addition obesity-induced
inflammatory cytokines, such as TNF-α, and ER stress result in increased JNK phosphorylation.
Moreover, ROS are highly abundant during obesity due to enhanced oxidative phosphorylation
in mitochondria and increased ER folding capacity, and may further enhance JNK activation.
Activated JNK then leads to activation of AP-1 target genes and is able to interfere with insulin
signaling by inhibitory phosphorylation on IRS-proteins.
As mice lacking TNF-α are protected from obesity-induced insulin resistance (Uysal
et al. , 1997), and TNF-α is an important inducer of JNK signaling, consequently JNK pos-
sess a crucial role in the regulation of inflammation-induced insulin resistance (Sabio &
Davis, 2010).
Indeed, a role for JNK to interfere with insulin signaling was shown for the JNK-1 protein
isoform. It was shown that JNK-1 phosphorylates IRS1 specifically at serine residue 307,
which leads to the inhibition of IRS-1 and therefore further downstream insulin signal-
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ing (Aguirre et al. , 2000). In addition, a conventional JNK-1 knockout, but not JNK-2,
in obese mice, leads to reduced adiposity and improved insulin resistance, revealing a
central role for JNK-1 in metabolic regulation (Hirosumi et al. , 2002).
In an attempt to specify in which peripheral organ JNK-1 exerts its primary effects, JNK-
1 was inactivated using several approaches in different tissues (Sabio et al. , 2008, 2009,
2010) (for review see (Belgardt et al. , 2010b)). However, none of these models recapitu-
lated the effects seen in the conventional JNK-1 knockout (Hirosumi et al. , 2002).
To maintain a healthy body, JNKs play a critical role, as they are strongly activated in
obesity and operate by inducing insulin resistance (Vallerie & Hotamisligil, 2010). How-
ever there is also increasing evidence that JNKs are selectively activated upon physical
exercise (Goodyear et al. , 1996).
1.5 Physical Exercise induced JNK Activation
In the late 1990’s the first evidence linking physical exercise and the activation of JNK was
established in rats (Goodyear et al. , 1996). Treadmill exercise lead to a two-to-three fold
increase of JNK activity in rat skeletal muscle. Cycle ergometer exercise in humans re-
vealed that this exercise-induced JNK activity is an intrinsic response to exercise from the
exercising leg. It was suggested that JNK could be responsible for the exercise-induced
transcriptional changes within the contracting skeletal muscle (Aronson et al. , 1998). One
year later, Boppart claimed that this exercise-induced JNK activation is a response to ec-
centric exercise-dependent injuries (Boppart et al. , 1999). Another year later, Boppart
showed a 7-fold increase in JNK phosphorylation compared to basal levels in human
skeletal muscle immediately after marathon running (Boppart et al. , 2000). Moreover,
training rats on a treadmill abrogated this exercise-induced JNK activation (Boluyt et al. ,
2003), indicating an attenuatiation of exercise-dependent stress responses. Additionally,
central increase in JNK activity was revealed in rat brains after swim exercise (peng Shen
et al. , 2004).
As these experiments were performed in non-obese healthy individuals, the question re-
mains as to what the physiological and molecular consequences of this exercise-induced
JNK activation are. The beneficial effects of exercise have been shown in rodent models
of diet induced obesity. Physical exercise reduced TLR4-signaling, JNK and IKKβ phos-
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phorylation, and decreased IRS1S307 phosphorylation in skeletal muscle, liver, and white
adipose tissue of diet induced obese rats, and thus reduces inflammation and insulin re-
sistance (da Luz et al. , 2011; Oliveira et al. , 2011). Additionally, swim exercise of diet
induced obese rats leads to a reduction of obesity-induced ER stress in adipose and hep-
atic tissue, accompanied by decreases in JNK and NFκB activities and improved insulin
sensitivity (da Luz et al. , 2011). In Zucker diabetic fatty rats, exercise lowers the levels
of hepatic JNK activation and subsequently the rate of IRS1S307 phosphorylation (Király
et al. , 2010).
Further beneficial effects of exercise were shown in mouse models of Alzheimer’s dis-
ease. Chronic exercise decreased phosphorylation of tau-protein within the hippocam-
pus, which correlated with a decline in JNK phosphorylation (Leem et al. , 2009). More-
over the protective effect of treadmill exercise in Alzheimer’s disease was proven by im-
proved cognitive function in water-maze test, and a decrease in hippocampal cell death
(Um et al. , 2011). These findings reveal exercise as a therapeutic intervention for the pre-
vention or treatment of Alzheimer’s disease, partly by attenuating JNK activation (Leem
et al. , 2009; Um et al. , 2011).
These protective effects of exercise were accompanied by a cytokine expression that dif-
fers from that induced by inflammation. In contrast to inflammation responses, which
lead to a drastic increase in the pro-inflammatory cytokine TNF-α, IL-6 is the first cy-
tokine present in the circulation during exercise, whereas the pro-inflammatory cytokines
TNF-α and IL-1β do not increase and rather decrease with exercise (Pedersen & Feb-
braio, 2008). In contrast to inflammation, exercise induces an increase in circulating anti-
inflammatory cytokines such as IL-10, IL-1Rα, and soluble TNFR-α, which is an inhibitor
of TNF-α (Ostrowski et al. , 1999; Pedersen & Febbraio, 2008).
This picture of cytokine expression during exercise indicates that exercise triggers an anti-
inflammatory environment, which may lead to the beneficial effects of physical activity
on metabolic diseases (Pedersen & Febbraio, 2008).
Furthermore, this exercise-induced cytokine response is mainly initiated by skeletal mus-
cle, which points to an endocrine function of this tissue.
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1.6 Skeletal Muscle - an Endocrine Organ
Skeletal muscle is the largest organ in the human body and one of its primary functions is
to manage physiological adjustments due to muscle contraction (Pedersen, 2011). In this
context, skeletal muscle was characterized as an endocrine organ, due to its ability to re-
lease cytokines termed myokines (for review see (Pedersen & Febbraio, 2008)). Myokines
either signal in an intrinsic fashion within the muscle, for example AMP-activated pro-
tein kinase (AMPK)-induced glucose uptake, or lead to systemic effects on other organs,
such as liver or adipose tissue (Pedersen, 2011). During recent years many cytokines
secreted by the skeletal muscle have been identified, particularly during fasting and ex-
ercise conditions (Pedersen & Febbraio, 2008; Pedersen, 2011). Under these conditions,
the most prominent myokine released by the skeletal muscle is IL-6, and functions to
stimulate glucose uptake within the skeletal muscle and enhance hepatic glucose pro-
duction. Other myokines include IL-15 as a mediator of muscle to fat crosstalk (Nielsen
et al. , 2007), and IL-8 whose expression is increased after 3 hours treadmill run (Nieman
et al. , 2003). All of these myokines operate to implement the tasks of the working skeletal
muscle.
IL-6 was discovered in 1980 (Weissenbach et al. , 1980) and classically signals through a
gp130-receptor-β (gp130Rβ)/IL-6-receptor-α (IL-6Rα) homodimer. Binding of IL-6 to the
receptor results in homodimerization and initiates the auto-phosphorylation and activa-
tion of the Janus-activated kinase (JAK). This activation leads to the phosphorylation at
Tyr757 in the murine gp130Rβ. JAKs then phosphorylate signal transducer and activator
of transcription (STAT)- 3 at tyrosine residues, which drives target genes, such as sup-
pressor of cytokine signaling (SOCS).
Not all cell types within the body express the IL-6Rα, yet they can still be stimulated by
a soluble form of the IL-6Rα (sIL-6Rα) in the course of trans-signaling (Mackiewicz et al. ,
1992; Taga et al. , 1989). The sIL-6Rα is generated by shedding of the membrane-bound IL-
6Rα by the metalloproteinases ADAM10 and ADAM17, or by translation of alternatively
spliced mRNA (Althoff et al. , 2000; Jones et al. , 2001; Matthews et al. , 2003). The role of
IL-6 in metabolic regulation is controversially discussed, however what is clearly estab-
lished is that activation of IL-6 mRNA and protein release are beneficial upon physical
exercise (Pedersen & Febbraio, 2008).
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1.6.1 Physical Exercise induced IL-6 activation
IL-6 has a prominent role in the metabolic adaptions to exercise, and indeed several stud-
ies claim that IL-6 is the ’exercise factor’ (Pedersen & Febbraio, 2008). In 1998, Ostrowski
and colleagues investigated participants of the Kopenhagen marathon and observed in-
creased plasma levels of IL-6 following the marathon (Ostrowski et al. , 1998). Consis-
tent with these findings, Steensberg and colleagues showed that the contracting human
skeletal muscle releases significant amounts of IL-6 into the circulation during prolonged
single-limb exercise (Steensberg et al. , 2000). It was first thought that the exercise-induced
IL-6 release was due to local damage within the working muscle, and that immune cells
were responsible for this increase in IL-6 (Bruunsgaard et al. , 1997; Nehlsen-Cannarella
et al. , 1997; Nieman et al. , 1998). However, since non-damaging muscle contractions can
also induce IL-6 activation, it is now established that contracting skeletal muscle is the
main source of IL-6 release upon exercise (Pedersen & Febbraio, 2008).
The intracellular pathways within the skeletal muscle leading to the activation of IL-6
upon an exercise stimulus, are controversial (Pedersen & Febbraio, 2008). The classical
signaling pathway leading to the activation of IL-6, was established in macrophages, in
which IL-6 activation is dependent on the activation of NFκB signaling pathway (Ped-
ersen, 2011). This inflammatory pathway starts with the binding of LPS (or other TLR-
stimulating factors) to TLR-4, which recruits the myeloid differentiation primary-response
protein 88 (MyD88) (Akira, 2003). MyD88 functions as an adapter molecule and trig-
gers the recruitment of IL-1 receptor-associated kinase (IRAK)- 1 and TNF-α receptor-
associated factor (TRAF)- 6. The interaction of the latter activates the inhibitor IκB.
Through phosphorylation of IκB by IKK, IκB is targeted for ubiquitination and subse-
quential proteasomal degradation. This leads to the activation and to the release of NFκB.
NFκB then translocates into the nucleus and activates classical inflammatory target genes,
such as IL-6 or TNF-α (Akira & Takeda, 2004; Pedersen, 2011).
However, since exercise is supposed to have beneficial effects on insulin sensitivity, it
would seem paradoxial that exercise induces IL-6 via the classical pro-inflammatory
pathway (Pedersen, 2011). Another mechanism for IL-6 induction might involve nitric
oxide (NO) production (Steensberg et al. , 2007). NO can directly alter signaling by either
redox-sensitive modifications or by nitrosation of proteins (Hemish et al. , 2003). Sev-
eral studies show an increase in NO production when the skeletal muscle is contracting
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(Balon & Nadler, 1994; Grange et al. , 2001; Lau et al. , 1998), and importantly Steensberg
revealed that inhibition of NO production during exercise leads to less increases in IL-6
mRNA in human skeletal muscle (Steensberg et al. , 2007).
Another stimulus for IL-6 activation upon exercise might be calcium. Mechanical load
during contraction stimulates significant calcium release from the sarcoplasmic reticu-
lum (Pedersen & Febbraio, 2008). The activity of nuclear factor of activated T-cell (NFAT)
is dependent on intracellular calcium concentrations and calcineurin, which is a ser-
ine/threonine phosphatase sensitive to elevated calcium concentrations. Therefore, NFAT
may represent the link between increased intramuscular calcium concentrations and the
activation of IL-6 (Dolmetsch et al. , 1998; Fiedler & Wollert, 2004). However 60 minutes
following concentric exercise IL-6 mRNA is increased without any changes in the nuclear
localization of NFAT (Chan et al. , 2004).
Inhibition of p38 phosphorylation in the cell’s nucleus leads to ablation of the IL-6 mRNA
response in stimulated myotubes (Chan et al. , 2004). In support, a reduced intramuscu-
lar glycogen content has been found to increase the phosphorylation of p38 (Chan et al.
, 2004). However, IL-6 transcription is rapid and in the beginning of exercise, therefore,
alternative signaling pathways must be responsible for the initial exercise-induced IL-6
expression (Pedersen & Febbraio, 2008) (Fig. 1.4).
Exercise-induced IL-6 influences systemic physiology (Fäldt et al. , 2004). Within the con-
tracting skeletal muscle, IL-6 acts in a paracrine manner to activate either the PI3-kinase
pathway resulting in glucose uptake, or the STAT3-AMPK pathway, which results in en-
hanced fat oxidation within the muscle (Carey et al. , 2006; van Hall et al. , 2003; Wolsk
et al. , 2010). Systemically it acts on the liver to increase hepatic glucose production, and
to the adipose tissue to induce lipolysis (Carey et al. , 2006; Febbraio et al. , 2004; Glund
et al. , 2007).
However, studies also show that IL-6 can have adverse effects when chronically acti-
vated, as in obesity or in patients with type 2 diabetes (Bastard et al. , 2000; Carey et al. ,
2004; Vozarova et al. , 2001). IL-6 was shown to induce insulin resistance in skeletal mus-
cle and liver (Kim et al. , 2004). In support, the action of IL-6 was shown to induce insulin
resistance and to repress hepatic glucose production (Sabio et al. , 2008). Nonetheless,
conventional IL-6 knockout mice exhibit impaired glucose tolerance that is reverted by
IL-6 and also develop mature-onset obesity (Wallenius et al. , 2002). Moreover, hepatic
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inactivation of IL-6Rα increases local systemic inflammation and insulin resistance, indi-
cating a protective role of IL-6 (Wunderlich et al. , 2010).
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Figure 1.4: Physical Exercise induced IL-6 activation in skeletal muscle.
Physical exercise leads to activation of IL-6 by a yet undefined signaling pathway. Exercise in-
creases the amount of nitric oxide and calcium within the muscle cells. Calcium triggers cal-
cineurin and may lead to an increase in IL-6 mRNA transcription via the transcription factor
NFAT. Additionally, low glycogen levels may represent a link between the exercise induced ac-
tivation of p38 and IL-6 mRNA transcription. Studies also revealed that JNK is activated in the
skeletal muscle upon an exercise stimulus. IL-6 fulfills its role in a paracrine and systemic manner,
leading to glucose uptake and fat oxidation within the contracting skeletal muscle and enhanced
hepatic glucose production and lipolysis in adipose tissue. (adapted from (Belgardt et al. , 2010b))
While acute increases in IL-6, i.e. during exercise, have a beneficial effect on periph-
eral metabolism, when chronically elevated, i.e. in obesity, IL-6 contributes to insulin
resistance.
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1.7 Obesity induced ER Stress
Incidences of metabolic diseases have strongly increased over the last years (Pedersen,
2011). Obesity induces ER stress and an increased demand on the endoplasmic reticulum
(ER) is thought to be a primary contributing factor to metabolic disfunction (Hummasti
& Hotamisligil, 2010; Ozcan et al. , 2004). The ER functions to balance calcium levels and
regulating folding, maturation, quality control, and trafficking of proteins (Hotamisligil,
2010). However, metabolic disorders are characterized by conditions challenging the ER.
These conditions include an increase in newly synthesized, unfolded proteins in the ER
lumen. To cope with these conditions of stress, the ER evolved the unfolded protein re-
sponse (UPR). The UPR is mediated by three ER membrane-associated proteins: inositol
requiring enzyme (IRE) 1, PKR-like eukaryotic initiation factor 2 α kinase (PERK), and
activating transcription factor (ATF) 6. In stress-free conditions these transmembrane
proteins are bound by chaperones (Fig. 1.5) (for review see (Hotamisligil, 2010)).
Upon activation, the endoribonuclease activity of IRE1 cleaves a 26 bp segment from the
mRNA of the X-box binding protein (XBP) 1, which creates an alternatively spliced form
of the transcription factor, XBP1s (Sidrauski & Walter, 1997). This excision results in con-
version of a 267 amino acid unspliced XBP1 protein (XBP1u) to a 371 amino acid spliced
XBP1 protein (XBP1s) (Glimcher, 2010). XBP1s then triggers a transcriptional program
and produces chaperones and proteins of the ER-associated protein degradation (ERAD)
to combat the ER’s stress situation (Hotamisligil, 2010).
Furthermore ER stress involves the activation of transmembrane protein ATF6. To be
fully functional, ATF6 needs to be reduced and can then translocate to the Golgi ap-
paratus. Here, ATF6 is processed by the serine protease site-1 protease (S1P) and the
metalloprotease site-2 (S2P) to produce an active transcription factor (Chen et al. , 2002).
Once activated ATF6 stimulates the expression of genes containing ER stress elements
(Hotamisligil, 2010).
Moreover, ER stress leads to the phosphorylation of eukaryotic translational initation fac-
tor (eIF2)-α at serine 51 by PERK (Shi et al. , 1998). This serine phosphorylation induces
eIF2α to reduce the rate of ternary complex formation, thereby inhibiting global protein
synthesis, which further attenuates the levels of stress on the ER (Harding et al. , 1999). If
the UPR is not able to counteract and relieve ER stress, apoptosis is initiated (Hetz et al.
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, 2006; Rao et al. , 2004). The induction of the UPR in the course of obesity-induced ER
stress, is able to attenuate stress-levels within the cell. However, activated UPR path-
ways may also lead to a further manifestation of obesity-induced deteriorations, partly
by activating JNK signaling via the IRE1 pathway.
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Figure 1.5: ER stress activates the UPR.
An accumulation of unfolded proteins within the ER-lumen results in activation of the three UPR
pathways. The endoribonuclease activity of IRE1 cleaves xbp1u mRNA to yield the active form
xbp1s. XBP1s transcription factor then translocates to the nucleus and induces gene expression for
ERAD and chaperone proteins. The transmembrane kinase PERK phosphorylates eIF2α, which
leads to inhibition of global translation activities. Additionally, ATF6 is reduced upon UPR acti-
vation, and translocates to the Golgi apparatus, in which it is processed to an active transcription
factor by S1P and S2P. Moreover, IRE1/XBP1-activity leads to induction of JNK signaling.
1.7.1 IRE1/XBP1-induced JNK activation
XBP1 was discovered over 20 years ago when attempting to define regulators of the ma-
jor histocompatibility complex (MHC) class 2 gene expression (Boothby et al. , 1988; Liou
et al. , 1988, 1990; Ono et al. , 1991). It belongs to the basic region-leucine zipper family
of transcription factors (Clauss et al. , 1996; Glimcher, 2010), and while is ubiquitously
expressed in all tissues, it is most abundant in the liver (Clauss et al. , 1993; Reimold et al.
, 2000). XBP1 was previously described for its role in immune function and plasma cell
differentiation (for review see: (Glimcher, 2010) and (He et al. , 2010).
Interestingly, IRE1/XBP1-signaling was also shown to activate the JNK pathway. Mice
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with XBP1-deficiency in the intestinal epithelium induced constitutive activation of IRE1,
which lead to JNK activation and TNF-α release (Podolsky, 2002). IRE1 induces JNK acti-
vation by recruiting the TRAF-2 (Urano et al. , 2000). Brain deficient XBP1 mice indicated
a link between ER stress and the development of insulin and leptin resistance, which is
accompanied by increased food intake and body weight in these mice (Ozcan et al. , 2009;
Zhang et al. , 2008). Furthermore, IRE1 and JNK are strongly activated in liver and adi-
pose tissue of obese mice (Ozcan et al. , 2004, 2006).
Recently, it was established that the pathways implicated in the UPR are not solely acti-
vated during ER-stress. Several studies also indicate a role for the IRE1/XBP1-signaling
in the regulation of glucose homeostasis. It was shown that genes involved in glucose
disposal and glycogen synthesis, e.g. glycogen synthase 1, are direct targets of XBP1
(Acosta-Alvear et al. , 2007; Lee et al. , 2008). A recent study established an interaction
between XBP1s and the Forkhead box O1 (FoxO1) transcription factor, which directs
FoxO1 to proteasomal degradation, and leads to improved serum glucose concentrations
in mouse models of insulin resistance, without affecting the XBP1s function on enhanc-
ing ER folding capacity (Zhou et al. , 2011).
In addition to its role on glucose homeostasis, XBP1 also affects lipid metabolism (Ho-
tamisligil, 2010), by regulating the transcription of genes involved in fatty acid synthesis.
This was shown in mice XBP1 deficiency specifically in the liver (Lee et al. , 2008). These
mice exhibit reductions in serum triglycerides and cholesterol, and when placed on a
high carbohydrate diet, the liver specific XBP1 deficient mice did not develop hepatic
steatosis (Lee et al. , 2008).
Taken together, these data demonstrate that UPR is linked to the development of obesity
and insulin resistance and furthermore XBP1 may contribute to changes in glucose and
lipid metabolism independently of the classical UPR signaling. However, further inves-
tigations using transgenic mouse model systems are required to validate these findings.
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1.8 Conditional Gene Targeting
The development of the the Cre/loxP-technology represents a milestone in conditional
gene targeting strategies (Kühn et al. , 1995; Rajewsky et al. , 1996). This system requires
both a mouse line with a loxP-flanked allele of the target gene (Sternberg & Hamilton,
1981; Sternberg et al. , 1986), and a mouse line expressing the Cre recombinase (Hoess
et al. , 1984, 1982), usually under the control of a tissue-specific promotor. Cre mediated
recombination between the two loxP sites then results in the excision of the targeted exon
(Hoess & Abremski, 1984) (Fig. 1.6 A).
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Figure 1.6: Cre mediated recombination.
(A) Expression of the Cre recombinase is driven by a tissue-specific promotor. Cre mediated
recombination between the two loxP sites (grey triangles) leads to complete deletion of the tar-
geted exon. (B) Expression of the indicator gene is prevented by a loxP flanked STOP-cassette.
Cre mediated recombination between the two loxP sites leads to complete deletion of the STOP-
cassette and expression of the indicator gene, resulting in a detectable indicator protein, e.g. eGFP.
(adapted from (Wunderlich, 2004))
For assuring a correct recombination by Cre, in terms of time-and tissue inducibility, it
is pivotal to monitor Cre mediated recombination events of indicator genes in vivo (Wun-
derlich et al. , 2001). To this end, reporter mice lines represent a necessary tool, in which
the expression of an indicator gene is prevented by a loxP-flanked STOP-cassette. Cre
mediated recombination between the loxP sites leads to deletion of the STOP-cassette,
and to expression of the indicator mRNA (Fig. 1.6 B). Appropriate indicator genes in-
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clude β-galactosidase or enhanced green fluorescent protein (eGFP) (Kühn et al. , 1995;
Stoller et al. , 2008). Indeed, the eGFP gene is widely used and is easyly detectable with-
out further enzymatic reactions (Heim et al. , 1995). The eGFP protein is derived from
the jellyfish Aequorea victoria and owes its fluorescence to a chromophore (Chalfie et al.
, 1994). However, to detect eGFP fluorescence, it must be highly expressed within the
cell, which requires the use of strong promotors to visualize Cre activity, e.g. the strong
chicken β-actin promotor (Rizzuto et al. , 1995).
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1.9 Objectives
Recent work has demonstrated that obesity-associated insulin resistance develops as a
consequence of inflammation-driven stress signaling pathways. Amongst them, JNK
signaling and ER stress play a prominent role. In order to gain mechanistical insights
into the stress signaling pathways that link obesity and inflammation, this thesis aims at
generating mouse models that carry genetic modifications in specific cell types to analyze
the development of obesity-induced insulin resistance.
Firstly, as the skeletal muscle presents the largest organ of the body and implements key
functions in maintaing whole body metabolic homeostasis, the stress-sensitive kinase
JNK-1 should be genetically ablated as well as constitutively activated in skeletal muscle
tissue of mice, to analyze the physiological consequences in these animals. Moreover, to
exclude synergistic activities between the JNK-1 and JNK-2 isoforms, a conditional JNK-2
knockout mouse should be generated that would be useful to analyze the cell-type spe-
cific effects of complete JNK inactivation in metabolic disorders.
Secondly, obesity and other metabolic disorders lead to induction of ER stress that manifests
as overabundance of unfolded proteins in the ER and leads to the activation of the tran-
scription factor XBP1. Here, a mouse model should be generated allowing for the cell-
type specific activation of the UPR-induced murine XBP-1 (mXBP1s) to analyze the phys-
iological consequences of ER stress-induced mXBP1s expression in numerous organs.
Thirdly, a novel Cre mouse strain should be generated that carries a 2A-Cre insertion into
the endogenous FABP4 STOP-codon, for its use to conditionally modify genes within the
adipose tissue.
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2.1 Chemicals and Biological Material
All chemicals are listed in table 2.1 and all enzymes are listed in table 2.2. Size markers
for agarose gel electrophoresis (Gene Ruler DNA ladder mix) as well as size markers for
SDS- polyacrylamide gel electrophoresis (Prestained protein ladder mix) were purchased
from Fermentas, St. Leon-Rot, Germany. Solutions were prepared with double distilled
water.
Table 2.1: Chemicals
Chemical Supplier
β-Mercaptoethanol AppliChem, Darmstadt, Germany
e-aminocaproic acid Sigma-Aldrich, Seelze, Germany
0.9 % saline (sterile) Delta Select, Pfullingen, Germany
1, 4-Dithio-DL-threitol (DTT) Sigma-Aldrich, Seelze, Germany
2, 2, 2-Tribromethanol (Avertin) Sigma-Aldrich, Seelze, Germany
Acetic acid Merck, Darmstadt, Germany
Acrylamide Roth, Karlsruhe, Germany
Agarose Peqlab, Erlangen, Germany
Agarose (Ultra Pure) Invitrogen, Karlsruhe, Germany
Ammonium Acetate Merck, Darmstadt, Germany
Ammoniumpersulfate (APS) Sigma-Aldrich, Seelze, Germany
Aprotinin Sigma-Aldrich, Seelze, Germany
Avidin Biotin Complex-Vectastatin Elite Vector, Burlingame, USA
Bacillol R© Bode Chemie, Hamburg, Germany
Barium hydroxide Fluka, Sigma-Aldrich, Seelze, Germany
Benzamidine Sigma-Aldrich, Seelze, Germany
Bovine serum albumin (BSA) Sigma-Aldrich, Seelze, Germany
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Bromphenol blue Merck, Darmstadt, Germany
Calcium chloride Merck, Darmstadt, Germany
Chloroform Merck, Darmstadt, Germany
Complete Mini Protease Inhibitor Cock-
tail Tablets
Roche, Basel, Switzerland
Count offTM NEN R© Research Products, Boston, USA
Desoxy-Ribonucleotid-Triphosphates
(dNTPs)
Amersham, Freiburg, Germany
Dextran sulfate Roth, Karlsruhe, Germany
Dimethlysulfoxide (DMSO) Merck, Darmstadt, Germany
di-Sodiumhydrogenphosphat Merck, Darmstadt, Germany
Enhanced chemiluminescence (ECL) Kit Perbio Science, Bonn, Germany
Ethanol, absolute AppliChem, Darmstadt, Germany
Ethidium bromide Sigma-Aldrich, Seelze, Germany
Ethylendiamine tetraacetate (EDTA) AppliChem, Darmstadt, Germany
Forene (isoflurane) Abbot GmBH, Wiesbaden, Germany
Glucose (20%) DeltaSelect, Pfullingen, Germany
Glycerol Serva, Heidelberg, USA
Glycine AppliChem, Darmstadt, Germany
HEPES AppliChem, Darmstadt, Germany
Hydrochloric acid (37%) KMF Laborchemie, Lohmar, Germany
Hydrogen peroxide Sigmal-Aldrich, Seelze, Germany
Insulin Novo Nordisk, Bagsvaerd, Denmark
Isopropanol (2-propanol) Roth, Karlsruhe, Germany
Magnesium chloride Merck, Darmstadt, Germany
Methanol Roth, Karlsruhe, Germany
Nitrogen (liquid) Linde, Pullach, Germany
Phenol AppliChem, Darmstadt, Germany
Phenylmethylsulfonylfluorid (PMSF) Sigma-Aldrich, Seelze, Germany
Phosphate buffered saline (PBS) Gibco BRL, Eggenstein, Germany
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Potassium chloride Merck, Darmstadt, Germany
Potassium hydroxide Merck, Darmstadt, Germany
Pyruvate Sigma-Aldrich, Seelze, Germany
Ready SafeTM, Liquid Scintillation Cock-
tail
Beckman Coulter, Fullerton, USA
Salmon Sperm DNA sodium salt Biomol, Hamburg, Germany
Sodium acetate AppliChem, Darmstadt, Germany
Sodium chloride AppliChem, Darmstadt, Germany
Sodium citrate Merck, Darmstadt, Germany
Sodium dodecyl sulfate AppliChem, Darmstadt, Germany
Sodium fluoride Merck, Darmstadt, Germany
Sodium hydroxide AppliChem, Darmstadt, Germany
Sodium orthovanadate Sigma-Aldrich, Seelze, Germany
Spermidine Sigma, Steinheim, Germany
Tetramethylethylenediamine (TEMED) Sigma-Aldrich, Seelze, Germany
Tissue Freezing Medium Jung, Heidelberg, Germany
Trishydroxymethylaminomethane (Tris) AppliChem, Darmstadt, Germany
Triton X-100 AppliChem, Darmstadt, Germany
Tween 20 AppliChem, Darmstadt, Germany
Western Blocking Reagent Roche, Mannheim, Germany
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Table 2.2: Enzymes
Name Company
AscI NEB, Frankfurt, Germany
AsiSI NEB, Frankfurt, Germany
BamHI NEB, Frankfurt, Germany
Bca DNA polymerase Takara, Otsu, Japan
BglI Fermentas, St. Leon-Rot, Germany
DNase, RNase-free Promega, Madison, WI, USA
EcoCRI Fermentas, St. Leon-Rot, Germany
EcoRI Fermentas, St. Leon-Rot, Germany
EcoRV NEB, Frankfurt, Germany
HindIII NEB, Frankfurt, Germany
MultiScript Reverse Transcriptase Applied Biosystems, Darmstadt, Germany
NcoI NEB, Frankfurt, Germany
Proteinase K Roche, Basel, Switzerland
RNase Inhibitor Applied Biosystems, Darmstadt, Germany
SacI NEB, Frankfurt, Germany
SacII NEB, Frankfurt, Germany
Trypsin Gibco, Paisley, UK
XbaI NEB, Frankfurt, Germany
2.1.1 Targeting Vectors
JNK-2 targeting vector was obtained from the European Conditional Mouse Mutagenesis
Program (EUCOMM, order PG00006A1D05). A detailed vector map is included in Fig-
ure 2.1 A. mXBP1s targeting vector was generated by Bruno Klisch. Hereto, the cDNA of
mXBP1s was cloned into the common STOP-eGFP-ROSA-CAGs (SERCA) vector (Klisch,
2006). A detailed vector map is included in Figure 2.1 B.
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Figure 2.1: JNK-2 and mXBP1s targeting vectors
(A) Map of the JNK-2 targeting vector used for the generation of a conditional JNK-2 allele. Indi-
cated are 5’ and 3’ arms for homologous recombination, FRT flanked neomycine resistance gene
(colored blue), loxP flanked exon 3, the gene for diphteria toxin A (colored red), as well as sites
for restriction enzymes. (B) Map of the mXBP1s targeting vector used for targeted insertion of
mXBP1s into the murine ROSA26 locus. The cDNA of mXBP1s was previously cloned into the
SERCA vector (Klisch, 2006). Indicated are short (SAH) and long (LAH) arms of homology, strong
chicken β-actin promotor (CAG) (colored light blue), neomycine resistance gene (neoR (colored
dark blue), Westphal-Stop-Sequence (WSS) (colored red, later referred to as STOP-cassette), cDNA
for mXBP1s (black), IRES/eGFP-cassette (colored green), and FRT- and loxP-sites as well as sites
for restriction enzymes.
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2.2 Molecular Biology
Standard methods of molecular biology were performed according to protocols described
by J. Sambrook, unless otherwise stated (J. Sambrook, 2001).
2.2.1 Isolation of Genomic DNA
For isolation of genomic DNA mouse tail biopsies were digested overnight in lysis buffer
(100 mM Tris pH 8.5, 5 mM EDTA, 0.2 % (w/v) SDS, 0.2 M NaCl, 500 mg/ml Proteinase K)
in a thermomixer (Eppendorf, Hamburg, Germany) at 56 ◦C. On the next day, DNA was
precipitated by adding an equivalent volume of 2-Propanol (100 %). DNA was washed
in 70 % (v/v) ethanol and the dried DNA pellet was redissolved in TE-buffer (10 mM
Tris pH 8.5, 5 mM EDTA, 500 mg/ml RNase A). A phenol/chloroform-extraction step
was added after overnight lysis for isolation of genomic DNA from tissues.
2.2.2 Quantification of Nucleid Acids
DNA and RNA concentrations were quantified by using a NanoDrop ND-1000 UV-Vis
Spectrophotometer (Peqlab, Erlangen, Germany). Sample absorptions at 260 nm and 280
nm were measured and an optical density of 1 corresponds to approximately 50 µg/ml
of double stranded DNA and to 38 µg/ml of RNA. To assess purity of nucleic acids, the
ratio of absorptions at 260 nm and 280 nm was calculated, as proteins absorb maximum
at 280 nm. An OD260/OD280 ratio of 2 refers to pure nucleic acids, lower values display
protein contaminations.
2.2.3 Polymerase Chain Reaction
PCR analysis was performed to detect loxP-flanked or Cre-targeted alleles. Customized
primers for PCR analysis were obtained from Eurogentec (Eurogentec, Cologne Ger-
many), and are listed in table 2.3. Reactions were done in a Thermocycler iCycler PCR
machine (Biorad, Munich, Germany). Amplifications were performed in volumes of 25
µl, containing a minimum of 50 ng template DNA, 25 pmol of each primer, 25 µM dNTP
mix, 10 x polymerase reaction buffer, and 1 unit of DNA polymerase. Standard PCR
programs started with 4 minutes of denaturation at 95 ◦C, followed by 25-40 cycles con-
sisting of denaturation at 95 ◦C for 45 seconds, annealing at primer-specific temperatures
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for 30-45 seconds, and elongation at 68 or 72 ◦C for 30 seconds, and a final elongation
step at 72 ◦C for 10 minutes.
Table 2.3: Primers used for genotyping
Name Sequence Targeted allele
5Cre ACGAGTGATGAGGTTCGCA ALFP-Cre
3Cre ATGTTTAGCTGGCCCAAATGT ALFP-Cre / FABP4-2A-Cre
FABP4-E1for GTGGGAACCTGGAAGCTTG FABP-2A-Cre
mck5 GTTCTTAAGTCTGAACCCGG MCK-Cre
mck3 GTCTGAGATGACATCGTCCAG MCK-Cre
Cre-intern-rev3 ATGTTTAGCTGGCCCAAATGT MCK-Cre
TL3472 GCACCTGGATGCTGACGAAG CAMKII-Cre
TL3473 CGCATAACCAGTGAAACAGCA CAMKII-Cre
JNK1loxNT ACATGTACCATGTACTGACCTAAG JNK-1
JNK1deltaNT CATTACTCTACTCACTATAGTAAC JNK-1
JNK1forNT GATATCAGTATATGTCCTTATAG JNK-1
JNK2F3 GGTGTGACCAGACCGAAGATTG JNK-2
JNK2R4 ACTGACCTGAGTGAGATCCCAGAGT JNK-2
5Flp GGCAGAAGCACGCTTATCG FLP-Del
3Flp GACAAGCGTTAGTAGGCACAT FLP-Del
Typ-rev-CAGS TGTCGCAAATTAACTGTGAATC mXBP1s
Typ-rev-wt GATATGAAGTACTGGGCTCTT mXBP1s
Typ-fwd AAAGTCGCTCTGAGTTGTTATC mXBP1s
5GK12 CCGCGGGCGATCGCCTAGG IL-6Rα
5IL6Ex3 CCAGAGGAGCCCAAGCTCTC IL-6Rα
3IL6A TAGGGCCCAGTTCCTTTAT IL-6Rα
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2.2.4 Southern Blot
For Southern blot analysis, 10-15 µg of genomic DNA were digested over night with the
appropriate restriction enzyme. The DNA fragments were separated by agarose gel elec-
trophoresis and transferred onto Hybond-XLTM-membranes (Amersham, Illinois, USA)
by alkaline capillary transfer. 80-100 ng DNA of the appropriate probe was radioactively
labeled with 2.5 mCiα32PdCTP (Amersham, Braunschweig) using the LaddermanTM La-
beling Kit (Takara, Japan). Primers for the generation of Southern blot probes are listed
in table 2.4.
Table 2.4: Primers used for the generation of Southern blot probes
Probe Primer Sequence
JNK1PA 5J1PA GATATCAGCTAGCTGAAGTGT
3J1PA GATATCATGGCTAAGCTGACAGACTCGG
JNK2P5 5J2P5 GCTTTGTGGAATAACAAGAACT
3J2P5 CACTAATTTTATGGTAATGTATTATG
JNK2P3 5J2P3 GCCTGCGGTGTTGCTTTTAATCTAAG
3J2P3 TAGACCTCTGGGTAGCAGCACACA
NeoR 5neo TGAATGAACTGCAGGACGAGGCA
3neo GCCGCCAAGCTCTTCAGCAAT
IL-6Rα IL-6R-5-probe-fwd TTGTAGTCTCCACCCACAAGCC
IL-6R-5-probe-rev AGCGAGCAACCTCAGACTCAGA
Probes targeting the ROSA26 locus were generated by restriction digest and are listed
in table 2.5. The DNA containing membranes were hybridized with the probes over night
at 65 ◦C in a hybridization oven. On the following day, unspecific bound probes were
washed off by using stringent solutions of SSC and SDS, ranging from 2 x SSC/ 0.1 %
SDS to 0.5 x SSC/ 0.1 % SDS. Radioactivity was proven with a Kodak MS film, incubated
on -80 ◦C together with the membrane in a film cassette.
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Table 2.5: Restriction enzymes used for the generation of Southern blot probes
Name Enzymes Origin Size
ROSA26 probe EcoRI A-04 plasmid (Mao et al., 1999) 1200 bp
BamHI
p26.1 SacII pROSA26-1 (Soriano, 1999) 1000 bp
XbaI
2.2.5 Gene Expression Analysis
Quantitative expression for mRNAs were determined by using whole-muscle isolated by
TRIzol (Invitrogen) or whole-liver, and hippocampus RNA isolated by RNeasy Kit (Qia-
gen, Hilden, Germany). Therefore the tissues were homogenized using an Ultra Turrax
homogenizer (IKA, Staufen, Germany). This RNA isolation followed a step of DNase di-
gestion (Promega GmbH, Germany). RNA was reversely transcribed with High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, USA) and amplified
by using TaqMan Universal Master Mix (Applied Biosystems). Relative expression of
mRNAs was determined by using standard curves based on cDNA derived from the re-
spective tissues, and samples were adjusted for total RNA content by house-keeping gene
hypoxyanthine guanine phosphoriboysl transferase (HPRT) 1 quantitative PCR. The re-
altime probes used in this study are listed in table 2.6.
For genes for which no commercial probe was available, custom probes were designed
(Tab. 2.7). Calculations were performed by a comparative cycle threshold (Ct) method.
This means that the starting copy number of test samples was determined in comparison
with the known copy number of the calibrator sample (ddCt). The relative gene copy
number was calculated as 2-ddCT. Quantitative PCR was performed on an ABI PRISM
7900 Sequence Detector (Applied Biosystems). Assays were linear > 4 orders of magni-
tudes.
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Table 2.6: Realtime PCR probes
All realtime PCR probes were obtained from Applied Biosystems, Foster City, USA.
Name Cat.-No.
mapk8 Mm00489514_m1
mapk8 human Hs01548508_m1
mapk9 Mm00444231_m1
mapk10 Mm00436518_m1
IL-6 Mm00446190_m1
XBP1 Mm00457359_m1
Dnajb9 Mm01622956_s1
Ddit3 Mm00492097_m1
Hspa5 Mm00517691_m1
Hprt1 Mm00446968_m1
Gusb Mm00446953_m1
Table 2.7: Custom-made realtime PCR probes
Probe Primer Sequence
JNK1 (∆) Probe AGTGTGTGCAGCTTATGATGCC
5JNK1 ATTGGAGATTCTACATTCACAGTCCTA
3JNK1 CATTCTGAAATGGCCGGCT
XBP1s Probe CGCAGCAGGTGCAGGCCCA
XBP-Sense GAATGGACACGCTGGATCCT
ABP-Antisense CAGAATCTGAAGAGGCAACAG
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2.3 Cell Biology
2.3.1 Cell Culture
Handling and passaging of cells was performed under a sterile hood (Hera Safe KS 12,
Heraeus Instruments) as previously described (Pal, 2008) unless otherwise stated. Em-
bryonic stem and embryonic fibroblast cells were maintained in an environment compris-
ing 95 % humidity, 37 ◦C, and 10 % CO2 saturation. The medium of ES cells was changed
every day, the medium of EF cells every 2-3 days. ES cell colony growth was stopped
before they became confluent and to maintain their pluripotency they were cultured in
the presence of leukaemia inhibiting factor (LIF) containing ES cell medium (DMEM, 15
%ES-fetal calf serum (FCS), 1 x non-essential amino acids, 1 mM sodium pyruvate, 2 mM
L-glutamine, 0.1 mM β-mercaptoethanol, 10 U/ml LIF supernatant). All targetings were
performed in Bruce4 embryonic stem cells (F Köntgen, 1993). 107 ES cells were trans-
fected with 40 µg of targeting vector DNA and were exposed to selection with geneticin
(G418) and/or ganciclovir. Selected clones were injected into blastocyts to give rise to
chimeric mice containing the desired transgene. Embryonic fibroblast cells were cultured
in DMEM-medium supplemented with 1 mM sodium pyruvate and 2 mM L-glutamine,
and were used as feeder cells for ES cell culture. Feeder cells are mitomycin C (mmc)
treated cells and were passaged three times.
2.3.2 Immunohistochemistry
White and brown adipose tissue of FABP4-2A-Cre mice was dissected and fixed overnight
in 4 % PFA and embedded for paraffin sections. Afterwards, 7 µm thin sections were de-
paraffinized and stained for GFP expression using rabbit anti-GFP antibody (Invitrogen,
Karlsruhe, Germany). A Zeiss Axioskop equipped with a Zeiss AxioCam for acquisition
of digital images using Spot Advanced 3.0.3 software was used to view the slides.
2.3.3 Flow Cytometry
Isolated peritoneal macrophages and Kupffer cells were analysed on a FACSCalibur and
data with regard to GFP fluorescence were evaluated using CellQuest software (Becton
Dickinson, Mountain View, USA).
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2.4 Biochemistry
2.4.1 Enzyme-Linked Immunosorbent Assay (ELISA)
Values for serum insulin and serum leptin were examined by ELISA (mouse/rat insulin
ELISA, #INSKR020, Crystal Chem., Downers Grove, USA; mouse leptin ELISA #900-019,
Ann Arbor, USA) according to the manufacturer’s protocol. The absorbance was de-
termined in a Precision Microplate Reader (Emax, Molecular Devices GmBH, Munich,
Germany).
2.4.2 Protein Extraction
Whole tissues (e.g. skeletal muscle) were homogenized with a polytron homogenizer
(IKA, Staufen, Germany) in protein lysis buffer (50 mM HEPES pH 7.4, 1 % Triton X-100,
0.1 M NaF, 10 mM EDTA, 50 mM NaCl, 0.1 % SDS, proteinase and phosphatase inhibitor
cocktail tablets (Roche, Mannheim, Germany)). Lysates were cleared by centrifugation
and protein concentration were determined using a NanoDrop ND-1000 UV-Vis spec-
trophotometer (Peqlab, Erlangen, Germany). Protein solutions were diluted with 4 x SDS
sample buffer (125 mM Tris-HCL pH 6.8, 5 % SDS, 43.5 % glycerol, 100 mM DTT, 0.02 %
bromphenol blue) to a final concentration of 10 mg/ml protein.
2.4.3 Western Blot Analysis
Isolated proteins were separated by SDS-polyacrylamide gel electrophoresis (10 %) and
transferred to PVDF membranes (Bio-Rad, Munich, Germany). Membranes were blocked
with 1 % of blocking reagent (Roche, Mannheim, Germany) for 1 hour at room tempera-
ture. Membranes were probed overnight at 4 ◦C with primary antibodies. A secondary
antibody was applied for 1 hour at room temperature. In between the incubation of first
and second and after the second antibody, membranes were washed with TBS-Tween
(TBS-T, 1 % Tween). After the last washing step, membranes were incubated for 1 minute
in Pierce ECL Western Substrate (Perbio Science, Bonn, Germany) and were exposed to
chemiluminescence films (Amersham, Braunschweig, Germany). Films were then devel-
oped in an automatic developer (Kodak, Germany). Antibodies were obtained from Cell
Signaling or Santa Cruz Technologies and are listed in table 2.8.
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Table 2.8: Primary antibodies used for Western blot
Name Origin Company
JNK-1/3 rabbit #sc-474, Santa Cruz Biotech., Santa Cruz, USA
p-JNK rabbit #4668, Cell Signaling, Danvers, USA
pan-AKT rabbit #4685, Cell Signaling, Danvers, USA
p-AKT rabbit #9271, Cell Signaling, Danvers, USA
PEPCK rabbit #sc-32879, Santa Cruz Biotech., Santa Cruz, USA
Calnexin rabbit #20880, Calbiochem, Darmstadt, Germany
p-IKKα/β rabbit #2697, Cell Signaling, Danvers, USA
p-IκB mouse #9246, Cell Signaling, Danvers, USA
IκB rabbit #4812, Cell Signaling, Danvers, USA
XBP-1 rabbit #sc-7160, Santa Cruz Biotech., Santa Cruz, USA
2.4.4 c-Jun N-terminal Kinase Assay
SAPK/JNK assays were performed according to the manufacturer’s protocol (#9810, Cell
Signaling, ). For this matter, tissues were homogenized in assay buffer and incubated
with c-Jun fusion beads protein overnight. After washing the protein-c-Jun fusion beads
were incubated with kinase buffer containing ATP, enabling bound c-Jun N-terminal ki-
nases to phosphorylate c-Jun. After 30 minutes the reaction was stopped and the samples
were loaded onto a 10 % SDS gel. Western blots were performed by using phospho-c-Jun
antibody.
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2.5 Mouse Experiments
General animal handling was performed as described by Hogan and Silver (B. Hogan,
1986; Silver, 1995).
2.5.1 Animal Care
All mice were cared within institutional care committee guidelines. All animal proce-
dures were conducted in compliance with protocols and approved by local government
authorities (Bezirksregierung Köln, Cologne, Germany). The procedures were also in
accordance with National Institutes of Health guidelines. Mice were fed either normal
chow diet (NCD) (Teklad Global Rodent 2018, Harlan) or a high fat diet (HFD) (C1057,
Altromin). Normal chow diet contains 53.5 % carbohydrates, 18.5 % proteins, and 5.5 %
fat (12 % of calories from fat). High fat diet contains 32.7 % carbohydrates, 20 % proteins,
and 35.5 % fat (55.2 % of calories from fat). Mice were housed in groups of 3 to 5 individ-
uals in a virus-free facility at 22 ◦C to 24 ◦C on a 12 h light / 12 h dark cycle. All mice had
access to water and food ad libitum. At the end of the study period, mice were sacrified
by lethal CO2 anaesthesia. Relevant organs were dissected and after shock-freezing in
liquid nitrogen stored at -80 ◦C until further preparation.
2.5.2 Mice
All mice were backcrossed on a C57/BL6 background. In all experiments, littermates car-
rying the loxP-flanked alleles but not expressing Cre recombinase were used as control
WT animals. Littermates containing both, the targeted loxP-flanked allele and the Cre
allele, were used for analysis at all times.
In this thesis, the following mouse models were used:
(A) To generate mice which lack JNK-1 specifically in skeletal muscle, mice express-
ing the Cre recombinase from the promotor of the muscle creatine kinase (MCK)
(Brüning et al. , 1998) were crossed to mice carrying a loxP-flanked exon 2 of the
JNK-1 gene (JNK-1FL/FL mice, (Belgardt et al. , 2010a)). Resulting offspring was in-
tercrossed to create JNK-1SM-KO male mice. JNK-1FL/FL mice served as wild type
control (WT) animals throughout the experiments.
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(B) To generate mice which heterozygously express a Cre inducible constitutively ac-
tive form of JNK-1 (JNK-1C) specifically in skeletal muscle, MCK-Cre mice were
crossed to homozygous JNK-1C mice. JNK-1C mice were kindly provided by Dr.
Claudia Wunderlich and PD Dr. Thomas Wunderlich. In JNK-1C mice, JNK-1 is
fused to a mutated version of its upstream kinase MKK7, which results in a con-
stant phosphorylation of JNK independent of intra-or extracellular stimuli.
(C) Heterozygous mXBP1s mice were generated in this thesis and crossed to heterozy-
gous CAMKII-Cre mice (Casanova et al. , 2001), or ALFP-Cre mice (Kellendonk et al.
, 2000), respectively, to generate a brain (mXBP1sCAMKII)- or liver (mXBP1sALFP)
specific overexpression of mXBP1s from the murine ROSA26 locus.
(D) To characterize newly generated FABP4-2A-Cre mice, animals were crossed with
two control mouse lines, a conditional knockin of FOXODN into the ROSA26 locus,
and a conditional knockout of the IL-6Rα gene, respectively.
(I) ROSA26-FOXODN mice were kindly provided by Dr. Marianne Ernst and PD
Dr. Thomas Wunderlich. FOXODN is a loss of function mutant of FOXO1.
The characteristic of FOXODN variants is a C-terminal truncation of the tran-
scriptional activation domain (TAD) at (∆ 256) of FOXO1 (Nakae et al. , 2001).
By this truncation in the FOXODN mouse mutant it functions as a dominant
negative (DN) inhibitor of transcription. The binding of endogenous FOXO1
and presumably other FOXO proteins to responsive DNA elements is inhib-
ited without the requirement of a stimulatory insulin signal (Belgardt et al. ,
2008). In this thesis, ROSA26-FOXODN mice served as a control to test the
functionality of the newly generated FABP4-2A-Cre mice. For this, homozy-
gous ROSA26-FOXODN mice were crossed to heterozygous FABP4-2A-Cre
mice. Offspring with a heterozygous allele of FOXODN served as control WT
mice, offspring with both a heterozygous FOXODN allele, and an allele for the
FABP4-2A-Cre (FOXODNFABP-4) were used to characterize the FABP4-2A-Cre
mouse.
(II) IL-6RαFL/FL mice were kindly provided by Dr. Peter Ströhle and PD Dr. Thomas
Wunderlich ((Wunderlich et al. , 2010)). In this thesis, IL-6RαFL/FL mice served
as a control to test the functionality of the newly generated FABP4-2A-Cre
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mice. For this, homozygous IL-6Rα FL/FL mice were crossed to heterozygous
FABP4-2A-Cre mice. Offspring with a heterozygous allele of IL-6RαFL/+ served
as control WT mice, offspring with both a heterozygous IL-6Rα FL/+ allele, and
an allele for the FABP4-2A-Cre (IL-6RαFABP-4) were used to characterize the
FABP4-2A-Cre mouse.
2.5.3 Genotyping of Mice
Genotyping for the different Cre lines and the targeted alleles was performed on genomic
DNA isolated from tail biopsies by PCR analysis using the primer listed in table 2.3.
Germline deletion for JNK-1FL/FL mice was excluded by using three primers within PCR,
one binding upstream the first loxP site and the others flanking the second loxP site.
2.5.4 Collection of Blood Samples and Determination of Blood Glucose and
Lactate Levels
Tail bleeding of mice was performed according to Hogan and Silver (B. Hogan, 1986; Sil-
ver, 1995). Blood glucose and blood lactate values were determined from whole venous
blood using an automatic glucose monitor (GlucoMen, A Menarini Diagnostics, Florence,
Italy) or an automatic lactate monitor (Accutrend Plus, Roche Diagnostics, Mannheim,
Germany).
2.5.5 Analysis of Body Composition (NMR)
Whole body composition of live animals was determined in vivo by nuclear magnetic
resonance (NMR) using the NMR Analyser Minispec (Minispec mq 7.5, Bruker Optik,
Ettlingen, Germany). Radiofrequency pulse sequences are transmitted into mouse tissue,
which are then retransmitted by hydrogen atoms in the tissue. These are the signals the
minispec detects. Amplitude and duration of the signals are related to properties of the
material.
2.5.6 Glucose, Insulin, and Pyruvate Tolerance Test
Glucose and pyruvate tolerance tests (GTT, PTT) were performed on animals fasted for
16 h prior the experiment. For the insulin tolerance tests (ITT) random fed mice were
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used. Animals were injected with either 2 g/kg body weight of glucose or pyruvate (2
g/kg dissolved in 0.9 % saline solution) or 0.75 units/kg body weight of human regu-
lar insulin (Novo Nordisk, Bagsværd, Denmark, diluted in 0.9 % saline solution) into
the peritoneal cavity. Blood glucose concentrations were determined from tail blood by
using an automated glucose monitor (GlucoMen, A Menarini Diagnostics, Mannheim,
Germany) for the indicated time points.
2.5.7 Insulin Signaling
To directly test insulin signaling, 16 h fasted mice were anesthetized by intraperitoneal
injection of Avertin (Sigma-Aldrich, Seelze, Germany). Samples (125 µl) of 0.9 % saline
with/without 5 U of insulin (Novo Nordisk, Bagsværd, Denmark) were injected into the
inferior vena cava. Samples were collected 2 (liver) and 5 (skeletal muscle) minutes after
injection.
2.5.8 Isolation of Adipocytes and Stromal Vascular Fraction
For the isolation of adipocytes and stromal vascular fraction, epigonadal fat pads of
mice were removed and subsequently incubated in collagenase solution (1 mg/ml in
DMEM/F12 1:1 medium) for 45 minutes at 37 ◦C to isolate adipocytes. Digested tis-
sues were centrifuged for 5 minutes at 2.500 rpm. The upper phase contains adipocytes,
whereas the pellet represents the stromal vascular fraction including preadipocytes, macrophages
and other cell types. The adipocytes were further centrifuged (5 min, 13.000 rpm) to ex-
tract the nuclei. The pellet of the stromal vascular fraction was resuspended in erythro-
cyte lysis buffer (154 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA) and incubated for 10
min at room temperature to destroy erythrocytes.
2.5.9 Isolation of Primary Peritoneal Macrophages
For the isolation of primary peritoneal macrophages, mice were injected intraperitoneally
with 2 ml of thioglycolate medium (4 % in PBS) to induce a sterile peritonitis. 4 days after
injection the mice were sacrified and cells were collected by peritoneal lavage with sterile
PBS. After a subsequent centrifugation step, the cells were resuspended in erythrocyte
lysis buffer for 3 minutes at room temperature. Cells were then subjected to FACS analy-
sis.
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2.5.10 Isolation of Kupffer Cells
For the isolation of Kupffer cells, mice were anesthetized and the liver was floated with
10 ml of sterile PBS via the vena carva. Next, the liver was dissected and meshed up using
2ml DMEM and a cell strainer. Cells were centrifuged for 5 minutes at 600 rpm. The
resuspended cell pellet was subjected to FACS analysis.
2.5.11 Food Intake
Daily food was calculated as the average intake of chow from custom made food racks
within the time stated. For this manner, mice were acclimated to the settings for at least
five days. Weight of the racks was determined daily.
2.5.12 Indirect Calorimetry
The Phenomaster system (TSE Systems, Bad Homburg, Germany) was used to deter-
mine indirect calorimetry, food intake and calorimetry of the mice. The parameters were
measured with the help of Dr. Hella Brönneke and Jens Alber as previously described
(Belgardt et al. , 2010a). The system allows measurement of metabolic performance and
activity-monitoring by an infrared light-beam frame. Mice were allowed to adapt to the
system chambers in training cages for five days. Food and water were provided ad libitum
in the appropriate devices and were measured by the build-in automated instruments.
Presented data are average values obtained in these recordings.
2.5.13 Treadmill
Exercise experiments were performed on a treadmill (TSE Systems, Bad Homburg, Ger-
many) with the help of Dr. Hella Brönneke and Jens Alber (Fig. 2.2). An electrical stimuli
was triggered and applied (0.2 mA, max. 8 sec) every time a mouse stopped running
due to falling or exhaustion. Mice used in this study were only familiarized to but not
trained on the treadmill. Therefore, the mice were adapted and familiarized to sound
and movement of the treadmill on the first four days.
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Figure 2.2: Treadmill
For exercise experiments mice were forced to run a treadmill (TSE Systems, Bad Homburg, Ger-
many). Indicated are the running lanes for the analysis of six mice in parallel.
On the experimental day 5, the mice were forced to run for 30 minutes or 60 minutes,
respectively (Tab. 2.9).
Table 2.9: Treadmill Protocol
Day Velocity (m/s) Time (min) Sound Electric Stimulation
1 none 10 none none
none 10 Yes none
2 none 15 Yes none
0.05 15 Yes none
3 0.05 15 Yes none
0.1-0.12 15 Yes Yes
4 0.15-0.17 15 Yes Yes
0.17-0.22 15 Yes Yes
5 (Test) 0.22-0.25 30 / 60 Yes Yes
The velocity was starting at 0.22 m/s and reached a final pace of 0.25 m/s. Immedi-
ately after running, serum lactate and glucose values of the mice were determined by tail
blood and the mice were sacrified using CO2 anesthesia .
38
2 Materials and Methods
2.6 Computer Analyis
2.6.1 Densitometrical Analysis
To determine the intensity per mm2 of Western or Southern blot bands, the Quantity
One Software (Biorad, Munich, Germany) was used. After background subtraction, each
sample was normalized to an internal loading control (e.g. Calnexin, unphosphorylated
protein).
2.6.2 Statistical Methods
Data sets were analyzed for statistical significance by using two-tailed unpaired Stu-
dents’s t test. P values below 0.05 were considered significant. All displayed values are
means ± SEM. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. For visual clarity, instead of standard
deviations, means ± standard errors of the mean (SEM) are depicted in all figures.
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Whole body JNK-1 knockout mice revealed a central role for JNK-1 in linking inflam-
matory pathways to the pathogenesis of obesity and insulin resistance, as the mice were
protected from these diseases. To understand the cell-type specific functions of JNK-1 in
metabolic regulation in vivo, mice which lack or constitutively active JNK-1 specifically
in skeletal muscle were generated, and analyzed in terms of energy homeostasis. JNK-1
deficient mice were further utilised to understand synergistic activities between skeletal
muscle derived JNK-1 and the myokine IL-6 during physical activity.
ER stress is a central response of the cell to obesity. To further understand the UPR in
vivo, mice were generated with a brain- or liver specific overexpression of mXBP1s, and
were analyzed in terms of central and peripheral ER stress.
Many of the metabolic dysregulations associated with obesity originate within the adi-
pose tissue. To investigate these signaling pathways, in vivo genetic tools for specific
gain- or loss of function in adipose tissue is crucial. Therefore, mice expressing the Cre
recombinase from the promotor of the adipose tissue derived FABP-4 protein were char-
acterized.
3.1 The role of skeletal muscle derived JNK in metabolic
regulation
A crucial role for JNK-1 in obesity-associated insulin resistance was first shown in 2002
(Hirosumi et al. , 2002). Hirosumi and co-workers could establish that JNK-1 plays a cen-
tral role in obesity and obesity- induced insulin resistance. This thesis aims at exploring
the cell-type specific role of JNK-1 in the skeletal muscle, through analyzing genetically
engineered loss and gain of function approaches of JNK-1.
3.1.1 Increased JNK activity in skeletal muscle of obese mice
JNK is a stress-sensitive kinase which becomes activated upon stress-stimuli such as ac-
tivation of inflammatory mediators or free fatty acids, both of which are increased under
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obesity conditions (Vallerie & Hotamisligil, 2010). To this end, WT mice were exposed
to a high fat diet (HFD) from 3 weeks of age until 17 weeks of age. In order to show
an increased inflammation status of mice fed a HFD compared to mice exposed to a
normal chow diet (NCD), JNK-activity in skeletal muscle of these mice was examined.
JNK-activity was determined by the status of JNK phosphorylation and the degree of c-
Jun phosphorylation by performing a kinase assay. Skeletal muscle of mice fed a HFD
showed increased JNK phosphorylation (Fig. 3.1). In addition, increased phosphoryla-
tion of JNKs downstream target c-Jun in a kinase assay indicated a higher JNK-activity
upon HFD (Fig. 3.1).
These data demonstrate an elevated JNK activity in skeletal muscle during HFD- induced
obesity.
NCD HFD 
Muscle 
P-cJun 
AKT 
JNK 
P-JNK 
IB 
KA 
NCD HFD
IB
KA
pJNK
JNK
pC Jun
AKT
Skeletal Muscle
Figure 3.1: JNK activity in skeletal muscle is elevated in HFD-induced obesity.
Activation of JNK in skeletal muscle tissue in wild type mice is increased in mice fed a HFD com-
pared to mice fed a NCD, indicated by western blot analysis (IB) and JNK kinase activity assay
(KA). For western blot analysis antibodies against phosphorylated JNK and unphosphorylated
JNK were used. Antibodies detecting phosphorylated c-Jun were used to show increased JNK
activity on HFD in kinase assay. Antibodies against AKT were used as loading control.
3.1.2 Generation of a skeletal muscle specific knockout of JNK-1
In order to investigate the cell-type specific role of JNK-1 in skeletal muscle, mice were
created with a selective loss of JNK-1 in skeletal muscle. To this end, mice with a condi-
tional JNK-1 allele, in which exon 2 was flanked by loxP sites (JNK-1FL/FL mice, (Belgardt
et al. , 2010a)) were crossed with mice harboring the Cre recombinase under the control of
the muscle creatine kinase (MCK) promotor (Brüning et al. , 1998) (Fig. 3.2). The expres-
sion of MCK is highly restricted to skeletal muscle and heart, and reaches it maximum at
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10 days after birth (Brüning et al. , 1998; Johnson et al. , 1989). JNK-1FL/FL mice harboring
the MCK-Cre allele (JNK-1SM-KO) were used for analysis whereas JNK-1FL/FL mice served
as wild type controls (WT) throughout the experiments.
A
B
JNK-1!
JNK-1!
JNK-1!
JNK-1!
JNK-1!MCK! Cre!
MCK! Cre!
Figure 3.2: General scheme of mice with a selective deletion of JNK-1 in skeletal muscle.
(A) Mice, homozygous for a loxP-flanked allele of JNK-1 (JNK-1FL/FL) were crossed with mice
expressing Cre under the control of the MCK promotor. (B) Mice, heterozygous for both, a loxP-
flanked JNK-1 allele and MCK-Cre, were further intercrossed resulting in mice which lack JNK-1
specifically in skeletal muscle tissue (JNK-1SM-KO mice).
The loss of JNK-1 was confirmed by Southern blot, quantitative realtime PCR, and
western blot analysis from skeletal muscle extracts (Fig. 3.3). Using probe A in Southern
blot analysis yielded DNA fragments of 5.3 kb in size for the targeted allele (FL) and of
4.8 kb when the targeted allele was deleted by Cre-mediated recombination of exon 2 (∆)
(Fig. 3.3 A). Knockout of JNK-1 was only accomplished in skeletal muscle of JNK-1SM-KO
mice but not in liver or white adipose tissue (WAT) (Fig. 3.3 B). To confirm these data on
mRNA level, quantitative realtime PCR analysis was performed using probes specific for
JNK-1 and JNK-2, respectively. Expression of JNK-1 mRNA was diminished by 95 % in
skeletal muscle of JNK-1SM-KO mice whereas expression of JNK-2 remained unchanged
between the genotypes (Fig. 3.3 C). Moreover, Western blot analysis confirmed the ab-
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sence of JNK-1 protein in skeletal muscle of JNK-1SM-KO mice, whereas JNK-1 protein
expression in the liver was comparable between WT and JNK-1SM-KO mice (Fig. 3.3 D).
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Figure 3.3: Loss of JNK-1 specifically in skeletal muscle.
(A) Targeting strategy for conditional inactivation of the JNK-1 gene. Targeting vector containing
a FRT-flanked (black ovals) neomycine resistance cassette, loxP-flanked (black triangle) exon 2
and the gene for thymidine kinase (TK) essential for negative selection. Flp-mediated recombina-
tion of the neomycine resistance cassette and NcoI digest results in a 5.3 kb DNA fragment (FL)
when using probe A in Southern blot analysis. NcoI digest after Cre-mediated recombination
produces a 4.8 kb fragment (∆) using the same strategy. (B) Southern blot analysis of genomic
DNA isolated from liver, skeletal muscle, and WAT of WT and JNK-1SM-KO mice using the be-
forementioned strategy. (C) Determination of relative JNK-1 and JNK-2 mRNA concentrations in
skeletal muscle of WT and JNK-1SM-KO mice by quantitative realtime PCR (n=6). (D) Western blot
analysis of protein lysates isolated from skeletal muscle (upper panel) and liver (lower panel) of
WT and JNK-1SM-KO mice using JNK-1 and AKT (loading control) antibodies. Values are means
± SEM; ***, p ≤ 0.001.
Taken together, these data confirm a sufficient deletion of JNK-1 specifically in skeletal
muscle tissue of mice and represent a reasonable model to investigate a skeletal muscle
specific JNK-1 deficiency.
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3.1.3 Unaltered energy homeostasis in JNK-1SM-KO mice
JNK-1 complete knockout mice exhibit a decrease in body weight gain and show de-
creased levels of body fat under obese conditions (Hirosumi et al. , 2002). To investigate
the impact of JNK-1 in skeletal muscle on the development of obesity, body weight gain
of male WT mice and JNK-1SM-KO mice was monitored from week 3 of age until week
17 of age when feeding both, NCD and HFD. However, this analysis revealed no differ-
ences between the genotypes on NCD (Fig.3.4 A). Furthermore, when feeding a HFD,
JNK-1SM-KO mice developed obesity similar to WT mice (Fig.3.4 B).
3 6 9 12 1815
0
10
20
30
40
JNK-1SM-KO
WT
Age (weeks)
Bo
dy
 w
eig
ht
 (g
)
3 6 9 12 1815
0
10
20
30
40
JNK-1SM-KO
WT
Age (weeks)
Bo
dy
 w
eig
ht
 (g
)
A B
Figure 3.4: Body weight of JNK-1SM-KO mice.
(A) Average body weight of WT (open squares) and JNK-1SM-KO mice (black squares) fed a NCD
(n=16). (B) Average body weight of WT and JNK-1SM-KO mice fed a HFD (n=23). Values are
means ± SEM.
Consistent with these findings, body fat content of JNK-1SM-KO mice was indistin-
guishable from that of WT mice, although both, JNK-1SM-KO and WT mice displayed
similar increases in body fat content under HFD conditions when compared to NCD
(Fig. 3.5 A). In addition, the weight of epigonadal fat pads was unchanged between WT
and JNK-1SM-KO mice under both NCD and HFD, respectively (Fig. 3.5 B). In line with
these data, the concentrations of circulating serum leptin, an indirect measurement for
body fat content, were unaltered between WT and JNK-1SM-KO mice, and significantly
increased to the same extent upon HFD in both genotypes (Fig. 3.5 C).
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Figure 3.5: Unaltered adiposity in JNK-1SM-KO mice.
(A) Body fat content of WT and JNK-1SM-KO mice fed a NCD and HFD was determined by NMR
at week 17 of age (n=25). (B) Weight of epigonadal fat pads from WT and JNK-1SM-KO mice fed a
NCD and HFD at week 17 (n=25). (C) Serum leptin concentrations of WT and JNK-1SM-KO mice
fed a NCD and HFD at the age of 17 weeks were determined by ELISA (n=10). Values are means
± SEM. ***, p ≤ 0.001.
Next, naso-anal length of JNK-1SM-KO and WT mice was measured, since mice with
a deletion of JNK-1 in the central nervous system (CNS) and pituitary showed reduced
somatic growth (Belgardt et al. , 2010a). Here, although HFD caused a significant increase
in length in JNK-1SM-KO and WT mice, no alterations were detectable in body length
between the genotypes, indicating that skeletal muscle derived JNK-1 does not influence
somatic growth (Fig. 3.6).
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Figure 3.6: Body length of JNK-1SM-KO mice.
Naso-anal length of WT and JNK-1SM-KO mice fed a NCD and HFD at week 17 of age (n=25).
Values are means ± SEM. ***, p ≤ 0.001.
According to unchanged body weight and body fat mass in JNK-1SM-KO mice, determi-
nation of daily food intake revealed no alteration between the genotypes, although food
intake was significantly increased upon HFD in both, WT and JNK-1SM-KO mice (Fig. 3.7
A).
As energy intake was not affected, energy expenditure was assessed in WT and JNK-
1SM-KO mice. This analysis revealed unaltered oxygen consumption and carbon dioxide
production in JNK-1SM-KO mice during both day and night phases under both nutritional
states (Fig. 3.7 B). In line with these findings, an unaltered ratio was observed between
O2 and CO2 depicted in the respiratory exchange ratio (RER) between the genotypes.
However, RER was decreased upon HFD in both genotypes demonstrating the effect of
feeding a HFD since a RER value close to 0.8 represents the intake of more fat as a food
source (Fig. 3.7 C). Moreover, basal heat production in JNK-1SM-KO mice was indistin-
guishable to WT animals during both day and night phase upon NCD and HFD (Fig. 3.7
D).
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Figure 3.7: Food intake and energy expenditure of JNK-1SM-KO mice.
(A) Daily food intake of WT and JNK-1SM-KO mice at the age of 14 weeks under both NCD
and HFD (n=8). (B) Energy expenditure revealed in phenomaster experiments by the daily and
nightly volume of O2-consumption and CO2-release of WT and JNK-1SM-KO mice at the age of
14 weeks upon both NCD and HFD (n=8). (C) Respiratory exchange rate (RER) of WT and JNK-
1SM-KO mice at the age of 14 weeks upon both NCD and HFD (n=8). (D) Daily and nightly heat
production measured in phenomaster experiments of WT and JNK-1SM-KO mice at the age of 14
weeks upon NCD and HFD (n=8). Values are means ± SEM. ***, p ≤ 0.001.
Taken together, these data show that JNK-1SM-KO mice exhibited a normal body com-
position and indicate that energy homeostasis is not affected by a skeletal muscle specific
JNK-1 deficiency under both normal and high fat diet conditions.
3.1.4 Unaltered glucose metabolism and insulin sensitivity in JNK-1SM-KO
mice
Mice lack JNK-1 in the whole body display lower glucose and insulin concentrations
(Hirosumi et al. , 2002) under obese conditions. Thus, glucose homeostasis and insulin
sensitivity of JNK-1SM-KO were investigated. Performing a glucose tolerance test revealed
no alterations in glucose homeostasis on NCD in both genotypes (Fig. 3.8 A). However,
unlike JNK-1 complete knockout mice, JNK-1SM-KO mice fed a HFD developed obesity-
induced hyperglycemia similar to WT mice (Fig. 3.8 B). In addition, insulin sensitiv-
ity was unaltered between WT mice and JNK-1SM-KO mice feeding a NCD, indicated by
an insulin tolerance test (Fig. 3.8 C). Upon HFD JNK-1SM-KO mice developed obesity-
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induced insulin resistance and hyperinsulinaemia, which was similar to WT mice (Fig.
3.8 D). Additionally, concentrations of serum insulin remained unchanged between WT
and JNK-1SM-KO mice under normal and high fat diet conditions (Fig. 3.8 E).
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Figure 3.8: Unaltered glucose metabolism and insulin sensitivity in JNK-1SM-KO mice.
(A) Glucose tolerance tests of WT and JNK-1SM-KO mice fed a NCD were performed at week 11 of
age (n=21). (B) Glucose tolerance tests of WT and JNK-1SM-KO mice fed a HFD were performed
at week 11 of age (n=21). (C) Insulin tolerance tests of WT and JNK-1SM-KO mice fed a NCD were
performed at week 12 of age (n=21). (D) Insulin tolerance tests of WT and JNK-1SM-KO mice fed
a HFD were performed at week 12 of age (n=21). (E) Serum insulin concentrations of WT and
JNK-1SM-KO mice at the age of 17 weeks fed a NCD or HFD were determined by ELISA (n=10).
Values are means ± SEM.**, p ≤ 0.01.
To investigate a functional insulin signaling cascade, insulin-stimulated AKT phos-
phorylation was determined in these tissues of WT and JNK-1SM-KO mice. Although
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JNK-1 complete knockout mice lack the obesity-induced inhibitory phosphorylation of
IRS-1 (Hirosumi et al. , 2002), no improvements in insulin-stimulated AKT phosphory-
lation were detectable in skeletal muscle, or liver of JNK-1SM-KO mice compared to WT
under both NCD and HFD (Fig. 3.9).
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Figure 3.9: Insulin signaling in skeletal muscle and liver of JNK-1SM-KO mice.
Insulin-stimulated AKT phosphorylation of skeletal muscle (upper panel) and liver (lower panel)
of WT and JNK-1SM-KO mice fed a NCD or a HFD, in Western blot analysis using phospho-AKT
and AKT (loading control) antibodies.
These data demonstrate that inactivation of JNK-1 in skeletal muscle does not protect
from HFD- induced hyperglycemia and hyperinsulinemia.
Moreover, inactivation of JNK-1 in skeletal muscle does not the phenotype in terms of
obesity and insulin resistance occurring in JNK-1 whole body knockout mice (Hirosumi
et al. , 2002).
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3.1.5 Exercise induces activation of JNK and IL-6 in skeletal muscle of WT
mice
The lack of JNK-1 in skeletal muscle did not result in alterations for the body’s energy
homeostasis. In particular upon HFD-induced obesity a loss of JNK-1 in skeletal muscle
did not result in improvements with regard to hyperglycemia or hyperinsulinemia.
However, an improvement of the metabolic balance can also be achieved by an increase
in physical activity. Upon physical activity, skeletal muscle executes the main work in
adapting the body to these conditions. Previous experiments established that during ex-
ercise the expression of the prototypical myokine IL-6 is strongly increased, albeit the
precise intracellular signaling events mediating this increase are not well understood
(Pedersen & Febbraio, 2008). Moreover, in 1998, for the first time an activation of JNK
in the course of exercise was revealed (Boluyt et al. , 2003). To determine the role of skele-
tal muscle derived JNK-1 on the exercise-induced expression of IL-6, JNK-1SM-KO mice
were analyzed upon treadmill exposure.
As data are missing revealing an exercise-induced activation of JNK in mice, first phos-
phorylation of JNK in skeletal muscle of WT mice was determined. Upon exercise, phos-
phorylation of JNK was drastically increased in skeletal muscle tissue of WT mice, both
after 30 minutes and 60 minutes of exercise, respectively, as demonstrated by Western
blot analysis (Fig. 3.10 A). Consistently, quantification of the phosphorylation state de-
termined a significant increase of JNK phosphorylation after exercise (Fig. 3.10 B).
These data demonstrate that JNK is activated in skeletal muscle in response to exercise.
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Figure 3.10: JNK is activated in skeletal muscle of WT mice upon exercise.
(A) Representative Western blot analysis of protein lysates from skeletal muscle of random fed WT
mice either at rest, or running for 30 or 60 minutes, respectively, using phospho-JNK and Calnexin
(loading control) antibodies. (B) Quantification of Western blot showing in (A). Quantification is
indicated by the quotient of signal intensities of phospho-JNK and Calnexin antibodies (n=6).
Values are means ± SEM. **, p ≤ 0.01; ***, p ≤ 0.001
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Next, experiments were performed to assess an exercise-induced activation of IL-6 in
WT mice.
This analysis revealed a robust increase of IL-6 mRNA in skeletal muscle of WT mice after
30 minutes of exercise (Fig. 3.11). Moreover, as a consequence of an increasing anaerobic
milieu during exercise the values of lactate are increased, not only in the working skele-
tal muscle but also in circulation (Gladden, 2004, 2008). Thus, to confirm the impact of
treadmill running, lactate levels of WT mice were determined after 30 and 60 minutes of
exercise. Indeed, WT mice exhibited significantly elevated levels of lactate in the circula-
tion after 30 minutes of exercise (Fig. 3.11 B).
These data show that the exercise protocol applied in this study was sufficient to analyze
exercise dependent effects in the skeletal muscle.
Taken together, JNK and IL-6 are activated in skeletal muscle of WT mice in response to
physical activity. These findings are consistent with previous experiments revealing an
increase of IL-6 mRNA within the skeletal muscle upon exercise (Febbraio et al. , 2004).
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Figure 3.11: IL-6 mRNA expression is increased in skeletal muscle of WT mice upon exercise.
(A) Determination of IL-6 mRNA expression in skeletal muscle of random fed WT mice either at
rest or after 30 minutes of exercise by quantitative realtime PCR analysis (n=6). (B) Determination
of serum lactate values of WT mice either at rest or after 30 minutes of exercise. Values are means
± SEM. **, p ≤ 0.01.
3.1.6 Exercise induced IL-6 mRNA increase in skeletal muscle is blunted in
JNK-1SM-KO mice
A large body of evidence reveal that IL-6 is activated in skeletal muscle upon exercise
(data presented here, and review: (Pedersen & Febbraio, 2008)). However the underly-
ing mechanisms for this increase in IL-6 mRNA are yet to be identified. Hence, the impact
of a skeletal muscle specific inactivation of JNK-1 on the expression of IL-6 mRNA was
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examined. To this end, JNK-1SM-KO mice were applied in treadmill experiments.
As previously shown, investigation of IL-6 mRNA expression in skeletal muscle tissue
revealed that IL-6 mRNA expression was significantly increased in WT mice running for
30 minutes compared to resting mice (Fig. 3.11 + 3.12 A). Strikingly, this increase in skele-
tal muscle IL-6 mRNA as a consequence to exercise was blunted in the skeletal muscle of
JNK-1SM-KO mice (Fig. 3.12 A).
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Figure 3.12: IL-6 activation upon exercise is blunted in JNK-1SM-KO mice.
(A) Determination of IL-6 mRNA concentrations in skeletal muscle of WT and JNK-1SM-KO mice
either at rest or after 30 minutes of exercise by quantitative realtime PCR analysis (n=6). (B,C)
Western blot analysis of protein lysates from skeletal muscle of WT and JNK-1SM-KO mice ei-
ther at rest or after 30 minutes of exercise using (B) phospho-JNK, JNK-1, and (C) phospho-IKK,
phospho-IκBα, IκBα, and calnexin (loading control) antibodies. (D) Determination of serum lac-
tate values of WT and JNK-1SM-KO mice either at rest or after 30 minutes of exercise. (E) Exercise
endurance of WT and JNK-1SM-KO mice was determined as a quotient of running time and the
number of times a mouse hit the light beam. Values are means ± SEM. **, p ≤ 0.01; ***, p ≤ 0.001.
To examine whether skeletal muscle specific JNK-1 deficiency alters JNK phosphoryla-
tion in rested and exercised skeletal muscle, Western blot analysis of protein lysates from
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skeletal muscle of JNK-1SM-KO mice was performed before and after exercise. This anal-
ysis revealed that consistent with previous findings JNK is phosphorylated and thus ac-
tivated upon exercise. Furthermore this analysis demonstrated that the exercise induced
IL-6 activation is JNK-1 dependent, since phosphorylation of total JNK in the JNK-1SM-KO
mice was unaltered compared to WT mice although JNK-1 protein is absent (Fig. 3.12 B),
indicating a crucial role for JNK-1 in the exercise-dependent IL-6 activation.
Previously, experiments were performed demonstrating an activation of the NFκB-pathway
during exercise in rats (Ho et al. , 2005; Ji et al. , 2004). However, since exercise is be-
lieved to repress inflammation and to enhance insulin sensitivity (Pedersen & Febbraio,
2008), it seems paradoxical that the exercise-induced IL-6 activation relies on the pro-
inflammatory NFκB-pathway. Hence, studies were conducted to prove that the activa-
tion of IL-6 is independent of classical NFκB signaling. Western blot analysis of protein
lysates from skeletal muscle tissue revealed that 30 minutes of exercise exerted no effect
on the activation of IKK or the inhibitory phosphorylation of IκBα in skeletal muscle in
both WT and JNK-1SM-KO mice (Fig. 3.12 C), indicating that NFκB has no role in the
exercise-dependent IL-6 activation.
Supporting data from the Febbraio-group confirmed the findings presented here. Whitham
et al. could show that JNK is activated in C2C12 cells upon electric pulse stimulation
(Whitham et al. , 2012). Furthermore they found increased values of IL-6 mRNA and pro-
tein after this exercise stimulus. When the cells were treated at the same time with a JNK
inhibitor this IL-6 response is blunted at both the mRNA and the protein level of IL-6
(Whitham et al. , 2012).
In addition, treated C2C12 myotubes with the exercise stimulus exhibited no activation
of IKK in Western blot analysis (Whitham et al. , 2012). In parallel, treating the exercise
stimulated cells with an IKK inhibitor had no impact on exercise induced IL-6 activation
(Whitham et al. , 2012).
Significantly, Whitham and colleagues showed a recruitment of the JNK-1 induced tran-
scription factor AP-1 to the IL-6 promotor, indicating a direct link between the activation
of JNK and induction of IL-6 mRNA expression (Whitham et al. , 2012).
To reveal the significance of exercise in JNK-1SM-KO mice, circulating lactate values were
compared between rest and after 30 minutes of exercise in JNK-1SM-KO and WT mice.
This analysis revealed that JNK-1SM-KO mice displayed significantly increased serum val-
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ues of lactate when compared to WT mice (Fig. 3.12 C), indicating decreased exercise
performance in treadmill experiments. However, exercise endurance of JNK-1SM-KO mice
was unaltered when compared to WT mice (Fig. 3.12 D).
Taken together, knockout of JNK-1 in skeletal muscle abolishes exercise dependent in-
crease of IL-6 mRNA. While littermate control mice exhibited an increase in skeletal
muscle IL-6 mRNA following 30 minutes of exercise on a treadmill, this effect was ab-
rogated in JNK-1SM-KO mice. This highlights a novel role for JNK-1 in the requirement
for exercise-induced increases in IL-6 mRNA expression in skeletal muscle.
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3.1.7 Generation of a JNK-1 gain of function mouse in skeletal muscle
Loss of function of JNK-1 in skeletal muscle did not alter mouse energy homeostasis and
metabolism. However, these parameters were also addressed with a JNK-1 gain of func-
tion approach. For this, human JNK-1 was fused to a mutated version its upstream kinase
MKK7 (MKK7D, (Y Wang, 1998)). This results in a constant phosphorylation of JNK-1 by
MKK7 independent of inflammatory stimuli.
The cDNA of the fusion protein (JNK-1C) was integrated into the murine ROSA26 locus.
The expression of JNK-1C was prevented by a loxP-flanked STOP-cassette. In order to in-
duce this constant JNK-1 activation specifically in skeletal muscle, mice homozygous for
JNK-1C were crossed with mice heterozygous for the MCK-Cre transgene. This resulted
in the generation of JNK-1SM-C mice, which express a Cre inducible constitutively active
JNK-1 protein specifically in skeletal muscle (Fig. 3.13).
MCK! Cre!STOP! JNK-1C!
Figure 3.13: General scheme of mice with an selective constitutive activation of JNK-1 in skele-
tal muscle.
Mice, homozygous for a JNK-1C allele (only one allele is depicted here) were crossed with MCK-
Cre expressing mice to induce a consititutive activation of JNK-1 selectively in skeletal muscle
(JNK-1SM-C).
Cre-mediated recombination leads to excision of the loxP-flanked STOP-cassette re-
sulting in expression of JNK-1C. Expression of JNK-1C was demonstrated by quantitative
realtime PCR analysis of total RNA from skeletal muscle tissue of WT and JNK-1SM-C
mice. Human JNK-1 mRNA was drastically increased in skeletal muscle of JNK-1SM-C
mice (Fig. 3.14 A). Comparing protein expression in skeletal muscle, liver, and WAT of
WT and JNK-1SM-C mice revealed the muscle-specific expression of the JNK-1C fusion
protein at 90 kDa (Fig. 3.14 B). As a control, JNK-1 was expressed in all three tissues
and in both, WT and JNK-1SM-C mice. To test the functionality of the construct a JNK
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kinase assay was performed. Increased phosphorylation of c-Jun, the downstream target
of JNK, was detectable in skeletal muscle of JNK-1SM-C mice indicating increased JNK
activity in these animals (Fig. 3.14 C).
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Figure 3.14: Generation of a JNK-1 gain of function approach in skeletal muscle.
(A) Determination of relative JNK-1 mRNA expression in skeletal muscle of WT and JNK-1SM-C
mice by quantitative realtime PCR (n=8). (B) Expression of the JNK-1(C) fusion protein only in
skeletal muscle of JNK-1SM-C mice indicated by Western blot analysis using JNK-1 and AKT
antibodies. (C) Functionality of the JNK-1C construct in skeletal muscle of JNK-1SM- mice was
revealed by increased phosphorylation of c-Jun in JNK kinase assay (KA) experiments using an-
tibodies against phospho-c-Jun and AKT (loading control).
These data confirm a skeletal muscle specific expression of a functional constitutively
active JNK-1 fusion-protein, which mimics HFD-induced inflammation even under NCD
conditions.
3.1.8 Unaltered energy homeostasis in JNK-1SM-C mice
A lack of JNK-1 in skeletal muscle did not alter energy and glucose homeostasis. Next,
the effect of a constitutively activation of JNK-1 on these parameters should be deter-
mined. Since the increased JNK-1 activation mimics HFD- induced JNK-1 activation,
energy homeostasis of JNK-1C mice was only determined upon NCD feeding. Body
weight of WT and JNK-1SM-C mice was monitored from weaning until 17 weeks of age
demonstrating no obvious differences between the genotypes (Fig. 3.15 A). To exclude
alterations in the somatic growth axis as observed in CNS-deficient JNK-1 mice (Belgardt
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et al. , 2010a), naso-anal length of JNK-1SM-C mice was measured. However, no differences
were revealed between WT and JNK-1SM-C mice (Fig. 3.15 B).
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Figure 3.15: Body weight and body length of JNK-1SM-C mice.
(A) The average bodyweight of WT mice was compared with JNK-1SM-C mice from 3 to 17 weeks
of age (n=25). (B) Naso-anal length of WT and JNK-1SM-C mice at week 17 of age (n=25). Values
are means ± SEM.
Consistent with these findings, body fat content and weight of epigonadal fat pads
were indistinguishable between WT and JNK-1SM-C mice (Fig. 3.16 A + B).
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Figure 3.16: Unaltered adiposity in JNK-1SM-C mice.
(A) Body fat content of WT and JNK-1SM-C mice was determined by NMR at week 17 of age
(n=25). (B) Weight of epigonadal fat pads from WT and JNK-1SM-C mice in week 17 of age (n=25).
(C) Serum leptin concentrations of WT and JNK-1SM-C mice at the age of 17 weeks were deter-
mined by ELISA (n=10). Values are means ± SEM.
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In line with this experiments, unaltered serum concentrations of leptin in JNK-1SM-C
mice were present (Fig. 3.16 C). According to the unchanged body weight gain in JNK-
1SM-C mice compared to WT mice, analysis of food intake of JNK-1SM-C mice revealed
no differences in daily caloric uptake (Fig. 3.17 A). Moreover, parameters of energy ex-
penditure were determined in JNK-1SM-C mice. This analysis revealed unaltered oxygen
consumption and carbon dioxide production in JNK-1SM-C mice (Fig. 3.17 B). In line with
this notion was an unchanged RER between the genotypes (Fig. 3.17 C) and also the
ability to produce heat remained unchanged in JNK-1SM-C mice when compared to WT
animals (Fig. 3.17 D).
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Figure 3.17: Food intake and energy expenditure of JNK-1SM-C mice.
(A) Daily food intake of WT and JNK-1SM-C mice at the age of 14 weeks (n=8). (B) Energy expen-
diture revealed in phenomaster experiments by the daily and nightly volume of O2-consumption
and CO2-release of WT and JNK-1SM-C mice at the age of 14 weeks (n=8). (C) Respiratory ex-
change rate (RER) of WT and JNK-1SM-C mice at the age of 14 weeks (n=8). (D) Daily and nightly
heat production measured in phenomaster experiments of WT and JNK-1SM-C mice at the age of
14 weeks (n=8). Values are means ± SEM.
Taken together, these data demonstrate that JNK-1SM-C mice exhibited a normal body
composition, and constitutively activation of JNK-1 in skeletal muscle has no effect on
parameters of energy homeostasis.
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3.1.9 Unaltered insulin sensitivity in JNK-1SM-C mice
Obese animals lacking JNK-1 in skeletal muscle develop insulin resistance, whereas an-
imals lacking JNK-1 in the whole body are protected against HFD- induced insulin re-
sistance (Hirosumi et al. , 2002). Here, the effect of a skeletal muscle specific constitutive
activation of JNK-1, on insulin sensitivity was investigated. Systemic insulin sensitivity
of JNK-1SM-C mice was examined by performing an insulin tolerance test, that indicated
no alterations between the genotypes (Fig. 3.18 A). In addition, serum insulin concentra-
tions remained unchanged between WT and JNK-1SM-C mice (Fig. 3.18 B). Moreover, the
ability of insulin to stimulate its signaling cascade was assessed in biochemical experi-
ments in JNK-1SM-C mice. These data indicated unaltered systemic insulin sensitivity as
indicated by insulin-induced AKT phosphorylation(Fig. 3.18 C).
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Figure 3.18: Unaltered insulin sensitivity in JNK-1SM-C mice.
(A) Insulin tolerance test of WT and JNK-1SM-C mice were performed at week 12 of age (n=21). (B)
Serum insulin concentrations of WT and JNK-1SM-C mice at the age of 17 weeks were determined
by ELISA (n=10). (C) Insulin-induced ATK phosphorylation in skeletal muscle (upper panel)
and liver (lower panel) of WT and JNK-1SM-C mice determined in western blot analysis with
antibodies against phosphorylated AKT and AKT (loading control). Values are means ± SEM.
These findings suggest that both the local and systemic insulin signaling cascade re-
mains unaffected by a constitutive activation of JNK-1 in skeletal muscle.
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3.1.10 Hepatic glucose production of JNK-1SM-C mice
The skeletal muscle is the major tissue responsible for glucose uptake, in particular dur-
ing contraction (Pedersen, 2011). Thus, glucose metabolism was investigated in JNK-
1SM-C mice. Mice lacking JNK-1 in the whole body remain glucose tolerant even when
exposed to diet-induced obesity (Hirosumi et al. , 2002). To investigate the effect of in-
creased JNK-1 activation in skeletal muscle on glucose homeostasis, a glucose tolerance
test was performed in WT and JNK-1SM-C mice. However, constitutive activation of JNK-
1 in skeletal muscle appeared to have no impact on glucose metabolism (Fig. 3.19 A),
as the ability to respond to glucose challenging was unaltered in JNK-1SM-C mice when
compared to WT mice.
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Figure 3.19: Hepatic glucose production in JNK-1SM-C mice.
(A) Glucose tolerance tests of WT and JNK-1SM-C mice were performed at week 11 of age (n=15).
(B) Pyruvate tolerance tests of WT and JNK-1SM-C mice were performed at week 13 of age (n=12).
(C) Determination of serum glucose concentrations of WT and JNK-1SM-C mice. (D) Western blot
analysis of protein lysates from liver tissue of fasted or random fed WT and JNK-1SM-C mice using
PEPCK and AKT (loading control) antibodies. Values are means ± SEM. *, p ≤ 0.05.
During fasting periods, the liver supplies glucose to maintain stable blood glucose
levels by mobilizing glucose from glycogen stores, and in a process in which pyruvate is
converted into glucose (Heppner et al. , 2010; Unger, 1971). This in vivo measurement of
the rate of gluconeogenesis determined significantly increased serum concentrations of
glucose after 60 and 120 minutes upon a pyruvate challenge in JNK-1SM-C mice indicating
an increased rate of hepatic gluconeogenesis (Fig. 3.19 B). Consistent with this observa-
tion, fasted serum concentrations of glucose at week 17 of age in JNK-1SM-C mice were
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slightly increased when compared to WT mice (Fig. 3.19 C).
Since the rate of hepatic gluconeogenesis is dependent on the rate-limiting enzyme phos-
phoenolpyruvate carboxykinase (PEPCK) (Harris et al. , 2002), the expression of PEPCK
was investigated in livers of mice which were either random fed or fasted for 16 hours. In
WT mice, expression of hepatic PEPCK protein was increased upon fasting. This fasting-
induced increase of PEPCK protein expression was also reflected in livers of JNK-1SM-C
mice. Strikingly, comparing fasted hepatic PEPCK protein of WT and JNKSM-C mice mice
revealed that PEPCK expression was elevated in mice which selectively activate JNK-1
signaling in skeletal muscle (Fig. 3.19 D), further underlining the finding of increased
hepatic glucose production in JNK-1SM-C mice.
As JNK-1 is constitutively activated in skeletal muscle, it remains unclear which signal
implements the crosstalk between skeletal muscle and liver tissue. Moreover, it was
shown that PEPCK expression can be induced by IL-6 (Banzet et al. , 2009). Consistently,
mice with a selective deletion of JNK-1 in adipose tissue exhibit decreased concentra-
tions of circulating IL-6 leading to a decreased hepatic glucose production under obese
conditions (Sabio et al. , 2008). Thus, the differential expression of IL-6 in skeletal muscle
and liver of WT mice was investigated. This analysis showed that skeletal muscle is the
main producer of IL-6 upon fasting, and IL-6 mRNA expression in skeletal muscle was
strongly increased in fasted mice when compared to IL-6 mRNA expression of random
fed mice (Fig. 3.20 A). Upon 16 hours of fasting, mRNA expression in skeletal muscle
was more than twofold upregulated when compared to the IL-6 mRNA expression of
random fed mice, with no further increase of IL-6 mRNA expression after 24 hours of
fasting (Fig. 3.20 A). Interestingly, the strength of IL-6 mRNA elevation upon fasting was
attenuated in WT liver tissue, though IL-6 activation was significantly increased after 16
hours of fasting (Fig. 3.20 B).
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Figure 3.20: IL-6 mRNA expression is increased upon fasting.
(A) Determination of IL-6 mRNA expression in skeletal muscle and liver of WT mice by quan-
titative realtime PCR analysis (n=6). (B) Determination of IL-6 mRNA expression in liver by
quantitative realtime PCR analysis. Mice were either random fed, fasted, fasted and injected with
glucose, or fasted and injected with insulin (n=6). (C) Determination of IL-6 mRNA expression
in skeletal muscle of WT and JNK-1SM-C mice by quantitative realtime PCR analysis (n=6-10).
(D) Determination of IL-6 mRNA expression in liver of WT and JNK-1SM-C mice by quantitative
realtime PCR analysis (n=6-10). Values are means ± SEM. *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001.
To reveal a correlation between the expression of IL-6 mRNA and glucose production,
mice were injected with acute doses of glucose or insulin, respectively, directly after fast-
ing. An acute bolus of glucose after fasting, mimicking feeding, almost reduced hepatic
IL-6 mRNA levels to that found in random fed mice (Fig. 3.20 B). However, an acute
bolus of insulin directly after fasting further elevated the hepatic IL-6 mRNA response to
threefold higher levels compared to IL-6 mRNA levels in fed mice (Fig. 3.20 B).
Insulin decreases circulating glucose and ipso facto inhibits hepatic glucose production
(Granner et al. , 1983; Mounier & Posner, 2006). Therefore, an increased IL-6 mRNA ex-
pression after acute insulin exposure suggests that IL-6 exhibits a role in inhibiting hep-
atic glucose production.
To test cell-type specific IL-6 mRNA expression in JNK-1SM-C mice, skeletal muscle and
liver were analyzed. While JNK-1SM-C mice comprised an elevated hepatic glucose pro-
duction, the mRNA expression of IL-6 in skeletal muscle was significantly reduced in
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fasted animals when compared to IL-6 mRNA expression in WT mice (Fig. 3.20 C).
To clarify the role of IL-6 in the livers of JNK-1SM-C mice, hepatic IL-6 mRNA expression
was examined. This analysis revealed unaltered IL-6 mRNA expression in livers of fasted
JNK-1SM-C mice when compared to WT mice (Fig. 3.20 D).
IL-6 was predicted to suppress hepatic glucose production, partly by inhibition of PEPCK
expression (Inoue et al. , 2006). As hepatic IL-6 mRNA expression was unaltered between
the genotypes, other metabolites may be responsible for the increase in hepatic glucose
production observed in JNK-1SM-C mice.
Taken together, mice constitutively activating JNK-1 in skeletal muscle displayed an el-
evated hepatic glucose production. However, the factors which transmit the crosstalk
between skeletal muscle and liver and are therefore responsible for this increase in glu-
coneogenesis remain unknown.
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3.1.11 Expression pattern of the JNK isoforms in tissues of WT mice
The JNK protein kinase family consists of three isoforms, JNK-1, JNK-2, and JNK-3, with
various splicing variants (Davis, 2000).
As no alterations in the development of obesity-associated insulin resistance in mice lack-
ing JNK-1 in skeletal muscle were found, compensatory effects by other JNK isoforms
cannot be excluded.
To determine the cell-type specific expression of all three JNK isoforms quantitative real-
time PCR analysis was performed from total RNA of numerous tissues obtained from 8
weeks old WT mice. In this analysis the value of JNK-1 expression was set to 1 and val-
ues obtained for JNK-2 and JNK-3 expression were correlated to that. Strinkingly, JNK-1
always showed the lowest expression level compared to JNK-2, wheras JNK-3 was only
expressed in brain, heart, testis, and pancreas though to a lower extent (Fig. 3.21).
Indeed, JNK-1 and JNK-2 were expressed in all tissues investigated. Interestingly, liver
and skeletal muscle tissue exhibited relatively high mRNA expressions of JNK-2 (Fig.
3.21). JNK-1 and JNK-2 perform similar functions as the activation of the transcription
factor AP-1 via phosporylation of its subunit c-Jun (Weston & Davis, 2007), compensatory
activities of JNK-2 when JNK-1 is missing can not be ruled out in the experiments pre-
sented here.
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Figure 3.21: Expression pattern of JNK isoforms in tissues of WT mice.
Determination of relative JNK-1, JNK-2, and JNK-3 mRNA expression in indicated organs of 8
weeks old WT mice by quantitative realtime PCR analysis (n=6). Values for JNK-1 expression
were set to 1, with exception for pancreatic tissue in which JNK-2 expression was set to 1. Values
are means ± SEM.
Thus, it might be necessary to investigate parameters of energy homeostasis in mice
lacking all JNK isoforms in the respective tissues.
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3.1.12 Generation of a loxP-flanked JNK-2 allele in mice
Analysis of mice lacking all three JNK isoforms is inevitable, since compensatory activi-
ties of other JNK isoforms are feasible. A conditional JNK-3 knockout mouse has already
been successfully generated (ref Martin Pal, DA). Here, conditional JNK-2 knockout mice
were generated by gene targeting.
For the conditional inactivation of JNK-2, the JNK-2 targeting vector was introduced into
the murine genome. Upon homologous recombination into the genome of murine em-
bryonic stem cells, the vector introduces a selection cassette into intron 2 of the JNK-2
gene and flanks exon 3 of the murine JNK-2 gene by two loxP sites (Fig. 3.22 A). The
JNK-2 targeting vector also exhibits a FRT-flanked neomycine resistance (neoR) cassette,
which is essential for the positive selection of ES cell clones. After transfection of the
pluripotent embryonic stem cells, the neoR gene enables selection of those ES cell clones,
which have stably integrated the JNK-2 construct into their genome. It is essential to
excise the neoR-cassette after establishing of the conditional JNK-2 allele, since the selec-
tion gene is transcriptionally active and its expression could interfere with transcription
of the JNK-2 gene. Upon Flp-mediated recombination at the FRT sites, the neoR cassette
is excised. Moreover, the JNK-2 targeting vector comprises the diphteria toxin A gene
as negative selection marker. Homologous recombination between the JNK-2 targeting
vector and the endogenous JNK-2 allele is mediated by 3.4 kb and 4.6 kb homologous
regions on both sides of the loxP-flanked exon 3 of the JNK-2 gene (Fig. 3.22 A).
Loss of exon 3 upon Cre-mediated recombination, and thus, splicing from exon 2 to exon
4 leads to a frameshift which produces a premature STOP-codon within exon 4 leading
to a non-functional JNK-2 protein. As a result, JNK-2 is conditionally inactivated in Cre
expressing cells.
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Figure 3.22: Generation of mice with a loxP-flanked allele of the murine JNK-2 gene.
(A) Targeting strategy to generate a conditional JNK-2 allele. The JNK-2 targeting vector exhibits
a FRT-flanked (black ovals) neomycine resistance (neo) gene and a loxP-flanked (grey triangles)
exon 3, and the gene for diphteria toxin A (DTA), essential for negative selection. 5’ short and 3’
long arms of homology are indicated. Homologous recombination between the targeting vector
and the endogenous JNK-2 allele leads to a homologous recombinant, which exhibits a loxP-
flanked exon 3 of the JNK-2 gene. For Southern blot analysis, HindIII digest of WT DNA produces
a 4 kb fragment using the 5’ probe, SacI digest of WT DNA results in a 8.2 kb fragment using
the 3’ probe. HindIII digest after homologous recombination results in 9.5 kb fragment using
the 5’ probe, SacI digest produces a 7.4 kb DNA fragment using the 3’ probe in Southern blot
analysis. (B,C) Identification of homologous recombinants of a conditional JNK-2 allele using
the (B) 5’ probe after HindIII digest and using the (C) 3’ probe after SacI digest in Southern blot
analysis. (D) Confirmation of single integrated homologous recombined JNK-2 ES cell clones
using the neoR-probe after HindIII digest in Southern blot analysis. (E) Germline transmission
for the conditional JNK-2 allele revealed by PCR analysis with the in (A) indicated primers (black
arrows).
The incorporation of the JNK-2 targeting vector DNA into the ES cell’s genome was
determined by Southern Blot analysis. After HindIII digest, hybridization with genomic
DNA on the membrane led to hybridization signals of 4 kb for the WT allele and of
9.5 kb for the targeted allele using the 5’ probe (Fig. 3.22 B). In turn, hybridization of
the 3’ probe yielded a 8.2 kb long fragment for the WT JNK-2 allele when digested with
SacI, whereas after successful homologous recombination, hybridization with the 3’ JNK-
2 probe resulted in a 7.4 kb fragment for the targeted allele (FL) (Fig. 3.22 C). Moreover,
hybridization with a radioactive labeled probe for the neomycine resistance cassette, neoR
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upon HindIII digest, produces a single band at 9.5 kb (Fig.3.22 D), revealing the single
integration of the construct into the endogenous JNK-2 locus.
To generate those conditional JNK-2 ES cell clones, 40 µg of linearised JNK-2 targeting
vector were electroporated in Bruce4 ES cells (F Köntgen, 1993), and 23 ES cell clones
were identified displaying both, the WT allele as well as the targeted JNK-2 allele. These
positive clones were expanded and clones F1 and H6 were injected into CB-20 blastocytes
and subsequently implanted into the uterus of pseudo-pregnant foster-mice. 5 chimeras
were born with an chimerism higher than 50 % for the ES cell clone F1. These chimeric
mice were backcrossed with C57BL/6 mice. Germline transmission of the targeted JNK-2
allele was proven by PCR analysis, which resulted in a 363 bp long DNA fragment for
the WT allele and a 335 bp long DNA fragment for the targeted JNK-2 allele when using
primers P1 and P2 (Fig. 3.22 E). Mice, positive for the targeted JNK-2 allele were crossed
with Flp-Deleter mice (Rodríguez et al. , 2000). Flp-mediated recombination led to exci-
sion of the neoR-cassette, which otherwise could interfere with JNK-2 gene expression.
Taken together, these data demonstrate the generation of mice with a conditional JNK-2
allele. Through the generation of the conditional JNK-2 allele, it is possible to exclude
compensatory activities between JNK-1 and JNK-2 (and JNK-3). The newly generated
JNK-2FL mice were intercrossed with JNK-1FL mice to create conditional double knock-
outs of JNK-1 and JNK-2 in the main metabolic target tissues such as brain, liver, skeletal
muscle, and WAT. However, since the JNK kinases are also activated during the UPR it is
of particular interest to investigate their role in the course of ER stress.
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3.2 Central and peripheral induction of ER stress
Obesity increases the demand of cells to produce and maturate proteins thereby exposing
the endoplasmic reticulum (ER) to a bulk of stress. To cope that high load of stress, the
ER initiates the unfolded protein response (UPR) (Ozcan et al. , 2004).
A main pathway of the UPR comprises the transmembrane-kinase inositol requiring en-
zyme 1 (IRE1) and its target X-box binding protein 1 (XBP1). ER stress activates the
endoribonuclease activity of IRE1, which subsequently processes mRNA of the XBP1 to
produce the active form of XBP1 (XBP1s). XBP1s then triggers a transcriptional cascade
to induce chaperones and proteins.
To unravel central and peripheral mechanisms of ER stress, mice were generated carrying
an allele for the murine XBP1s (mXBP1s) in their ROSA26 locus.
3.2.1 Targeted insertion of mXBP1s into the murine ROSA26 locus
To introduce the gene for mXBP1s into the murine genome the advantages of the ROSA26
locus were used. The ROSA26 locus was identified in 1991 by Friedrich and Soriano,
and is ubiquitously expressed, while its transcripts remain without functional relevance.
Due to its easy accessibility by homologous recombination it is widely used to introduce
transgenes into the murine genome (Belgardt et al. , 2008; Friedrich & Soriano, 1991; Mao
et al. , 1999; Possemato et al. , 2002; Soriano, 1999). In order to integrate the cDNA of
mXBP1s into the locus, a targeting vector was created, containing the strong chicken
beta-actin promotor (CAGS), a loxP-flanked neoR/STOP- cassette, cDNA of mXBP1s, and
a FRT-flanked internal ribosome entry site (IRES)/eGFP- cassette (SERCA vector) (Fig.
3.23 A) (Belgardt et al. , 2008).
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Figure 3.23: Generation of mice with targeted insertion of mXBP1s into the ROSA26 locus.
(A) Targeting strategy for insertion of mXBP1s into the murine ROSA26 locus. Targeting
vector containing the strong chicken beta-actin (CAG) promotor, loxP-flanked (grey trian-
gles) neoR/STOP-cassette, mXBP-1 cDNA (colored red), FRT-flanked (black ovals) IRES/eGFP-
cassette, and the gene for diphtheria toxin A (DTA) essential for negative selection. Homologous
recombination between the mXBP1 targeting vector and the WT ROSA26 locus leads to integra-
tion of the mXBP1 targeting vector into the genome. Southern blot analysis using ROSA26 probe
leads to DNA fragments of 16 kb for the wild type allele and 7.1 kb for the targeted allele upon
EcoRI digest. (B) Identification of homologous recombined ES cell clones for the insertion of
mXBP1s into the ROSA26 locus by using the ROSA26-probe after EcoRI digest in Southern blot
analysis. (C) Confirmation of single integrated homologous recombined mXBP1s ES cell clones
using the neoR-probe after EcoRI digest in Southern blot analysis. (D) Germline transmission for
the inserted mXBP1s allele revealed by PCR analysis with the in (A) indicated primers.
The incorporation of the targeting vector DNA into the genome after transfection in
ES cells was determined by Southern blot analysis of genomic DNA from the isolated ES
cell clones. For this, 107 Bruce4-ES cells were transfected with 40 µg linearized mXBP1s
targeting vector and subsequently selected with G418 containing medium. Eight days
after transfection 96 colonies were isolated as single clones and screened via Southern
blot analysis. Hybridization of the radioactively labeled ROSA26 probe (Mao et al. , 1999)
with the EcoRI digested ES cell clone DNA resulted in a 16 kb long DNA fragment for the
endogenous WT ROSA26 allele. After successful recombination of the mXBP1s targeting
vector DNA into the ES cell’s genome, hybridization with the ROSA26 probe led to an
additional fragment of 7.1 kb in size with the same signal intensity (Fig. 3.23 B). 44 pos-
itive clones, carrying both the WT and the mXBP1s allele were identified. A radioactive
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labeled neoR probe was used to check for single integration of the construct by recogniz-
ing the neomycine resistance cassette. Hybridization with this radioactively labeled neoR
probe results in a single band at 7.1 kb (Fig. 3.23 C).
Among these 44 positive clones, clone A10 was injected into blastocytes and implanted
into the uterus of pseudo-pregnant foster-mice. Chimeras with the highest degree of
chimerism were chosen for backcross with C57BL/6 mice. Germline transmission of
black offspring was revealed by PCR analysis of genomic tail DNA. For this, primers
were used which bind to sequences within the CAGS-promotor and the ROSA26 locus.
Using these primers resulted in a 570 bp DNA fragment for the WT allele whereas a 380
bp long fragment is amplified when the ROSA26 locus was successfully targeted. Indeed
from the first offspring 2 littermates carried the additional 380 bp band that were subse-
quently used to establish the ROSA-mXBP1s mouse line (Fig. 3.23 D).
Taken together, transgenic mice, which exhibit a Cre inducible mXBP1s allele, were gen-
erated. These generated ROSA-mXBP1s mice will help to gain insights into the mech-
anisms of the development of ER stress. As brain and liver represent major metabolic
targets for obesity-induced ER stress (Ozcan et al. , 2004), the newly generated ROSA-
mXBP1s mice were used to assess the impact of brain- or liver specific induction of ER
stress on mouse physiology.
3.2.2 Hippocampal expression of mXBP1s results in increased expression of
central and hepatic ER stress markers
The brain is a central regulator of energy homeostasis and ER stress in the brain is in-
creased during the course of metabolic disorders (Ozcan et al. , 2009; Zhang et al. , 2008).
To elucidate whether brain-derived ER stress also transmits to peripheral organs, the
newly generated ROSA-mXBP1s mice were crossed with two different Cre mouse lines,
which express the Cre recombinase either under the control of the promotor for the α-
subunit of calcium- calmodulin dependent protein kinase II (CAMKII-Cre, (Casanova
et al. , 2001)), or under the control of the albumin promotor constituted with the α-
fetoprotein enhancer (ALFP-Cre, (Kellendonk et al. , 2000)) (Fig. 3.24). While expression
of the CAMKII-Cre in mice starts shortly after birth and reaches it maximum at 6 to 8
weeks of age (Casanova et al. , 2001), expression of the albumin gene starts early dur-
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ing embryogenesis (Kellendonk et al. , 2000). CAMKII-Cre-mediated recombination of
the loxP-flanked neoR/STOP- cassette should result in mXBP1s expression in the brain
(mXBP1sCAMKII). Strongest expression of the CAMKII-Cre was observed in hippocam-
pus (Casanova et al. , 2001), therefore experiments presented here concentrated on Cre-
mediated recombination in the hippocampus. Recombination by the ALFP-Cre is only
occurring in liver parenchymal cells (Kellendonk et al. , 2000) (mXBP1sALFP).
A
B
STOP! mXBP1s!
STOP! mXBP1s!
CAMKII! Cre!
ALFP! Cre!
Figure 3.24: General scheme of mice with a selective overexpression of mXBP1s in hippocam-
pus (mXBP1sCamKII) and liver (mXBP1sAlfp).
(A) Mice, harbouring the mXBP1s allele were crossed with mice expressing Cre from the promotor
of CAMKII-α to induce mXBP1s overexpression in the brain (mXBP1sCamKII) (B) Mice, harbour-
ing the mXBP1 allele were crossed with mice expressing Cre from the ALFP promotor to induce
mXBP1s overexpression selectively in hepatocytes (mXBP1sAlfp).
While mice carrying both the ROSA-mXBP1s allele as well as the respective Cre al-
lele (mXBP1sCamKII, mXBP1sAlfp) were used for analysis, mice carrying only the mXBP1s
allele served as wild type control animals (WT). First, the functionality of the newly gen-
erated mXBP1s mouse was tested. To this end, total RNA isolated from the hippocampus
of WT mice, mXBP1sCamKII mice, and mXBP1sAlfp mice was isolated and quantitative
realtime analysis was performed. Hippocampi of mXBP1sCamKII mice exhibited signif-
icantly increased mRNA expression of XBP1s and XBP1u in mXBP1sCamKII mice when
compared to WT or mXBP1sAlfp mice, revealing that the mXBP1s construct is overex-
pressed from the ROSA26 locus in the hippocampus of mXBP1sCamKII mice (Fig. 3.25 A +
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B). However, also a significant increase in XBP1u mRNA in hippocampus of mXBP1sAlfp
mice was obeserved.
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Figure 3.25: XBP1s is overexpressed in hippocampi of mXBP1sCamKII mice.
Determination of XBP-1s (A), and XBP-1u (B), and ERdj4 (C), and GRP78 (D) mRNA concentra-
tions in hippocampus of WT, mXBP1sCamKII, and mXBP1sAlfp mice by quantitative realtime PCR
analysis (n=5-8). Values are means ± SEM. *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001
Consistent with elevated levels of XBP-1 mRNA was also a significant increased mRNA
expression of the XBP-1 target gene ER-BiP co-factor, ERDJ4, in hippocampus of mXBP1sCamKII
mice, whereas the hippocampal expression of ERDJ4 in mXBP1sAlfp remained unaltered
(Fig. 3.25 C). Moreover, increased markers of ER stress in hippocampi of mXBP1sCamKII
mice could also mediated by the PERK-eIF2α pathway, as indicated by significant ele-
vated mRNA expression of the molecular chaperone GRP78 in mXBP1sCamKII and mXBP1sAlfp
mice (Fig. 3.25 D).
Similar results were observed in livers of mXBP1sAlfp mice when crossing ROSA-
mXBP1s mice to ALFP-Cre mice. Indeed, mXBP1sAlfp mice exhibited a significant in-
creased expression of hepatic XBP1s and XBP1u mRNA (Fig. 3.26 A + B). Consistently,
this increase was confirmed on protein level by Western blot analysis. Expression of
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XBP1s protein (50 kDa) was highly elevated in the liver of mXBP1sAlfp mice, when com-
pared to hepatic XBP1s protein expression in WT or mXBP1sCamKII mice. Hepatic XBP1s
expression of the latter was slightly decreased (Fig. 3.26 B + C). Consistent with el-
evated XBP1 levels in the liver of mXBP1sAlfp mice, also the XBP1 target gene ERdj4
showed a significant increased mRNA expression, whereas ERdj4 expression in the liver
of mXBP1sCamKII mice remained unaltered (Fig. 3.26 D).
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Figure 3.26: XBP1s is overexpressed in livers of mXBP1sAlfp mice.
Determination of XBP-1s (A), and XBP-1u (B), ERdj4 (D), CHOP (E), GRP-78 (F) mRNA con-
centrations in liver tissue of WT, mXBP1sCamKII, and mXBP1sAlfp mice by quantitative real-
time PCR analysis (n=5-8). (C) Western Blot analysis of protein lysates from liver tissue of WT,
mXBP1sCamKII, and mXBP1sAlfp mice using XBP1 and Calnexin (loading control) antibodies. Val-
ues are means ± SEM. **, p ≤ 0.01; ***, p ≤ 0.001.
Taken together, these data demonstrate, that mXBP1s is selectively overexpressed in
either hippcampal regions or hepatocytes in mXBP1sCamKII and mXBP1sAlfp mice, respec-
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tively. Moreover, the expression of mXBP1s leads to the induction of ER stress in the re-
spective tissues.
To elucidate whether genetically induced ER stress through mXBP1s expression in hip-
pocampal neurons leads to ER stress in peripheral tissues, ER stress markers in skeletal
muscle and liver were determined. In skeletal muscle, the expression of the ER stress
markers XBP1, CHOP, GRP78, and ATF6 (not shown) were unaltered in mXBP1sCamKII
and mXBP1sAlfp mice when compared to WT mice (Fig. 3.27). Surprisingly, expression of
transcriptionally active XBP1s in the brain of mXBP1sCamKII mice resulted in significant
activation of hepatic C/EBP homologous protein (CHOP) (Fig. 3.26 E), which triggers
apoptic events in UPR responses (Hotamisligil, 2010). Additionally, increased mRNA
expression of the molecular chaperone GRP78 was observed (Fig. 3.26 F), although the
values for GRP78 in the livers of mXBP1sCamKII mice did not reach statistical significance
when compared to WT mice.
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Figure 3.27: Expression of ER stress markers in skeletal muscle of mXBP1sCamKII and
mXBP1sAlfp mice.
(A-D)Determination of XBP-1s (A), and XBP-1u (B), and CHOP (C), and GRP78 (D) mRNA con-
centrations in skeletal muscle of WT, mXBP1sCamKII, and mXBP1sAlfp mice by quantitative real-
time PCR analysis (n=5-8). Values are means ± SEM.
74
3 Results
Taken together, these data demonstrate that central induction of ER stress by overex-
pression of the transcriptionally active mXBP1s might contribute to peripheral ER stress
in liver tissue as determined by quantitative realtime PCR analysis.
In this thesis, ER stress was assessed in brain and liver, however it is also of intriguing
interest to determine the role of obesity-induced ER stress in the adipose tissue.
75
3 Results
3.3 Characterization of a novel adipose tissue specific Cre
recombinase mouse line
The adipose tissue plays a key role in metabolism. Besides its function as an endocrine
organ releasing adipokines, it also stores excessive lipids and thereby constitutes the ori-
gin of obesity (Ferris & Crowther, 2011). Thus, mouse knockout models as well as gain
of function approaches using the Cre/loxP- system are crucial to gain novel insights into
the mechanism of adipose tissue metabolism.
In order to generate a Cre mouse line, that is selectively active in adipose tissue derived
cells, the expression of Cre has to be placed under the control of an adipose tissue spe-
cific promotor. The promotor sequences of the fatty acid binding protein 4 (FABP4), also
termed adipocyte protein 2 (AP2), have been identified (Ross et al. , 1990), and, since it
is mainly expressed in differentiated adipocytes and functions as a fatty acid chaperone
(Hunt et al. , 1986), it is an appropriate candidate for the purpose to generate a novel adi-
pose tissue specific Cre mouse strain.
Here, a transgenic mouse line which express Cre specifically in FABP4-expressing cells
was generated by targeted knock-in of the cDNA for Cre recombinase into the endoge-
nous FABP4 locus and by applying the properties of the virus-derived 2A-peptide. The
2A-peptide was initially discovered in the foot-and-mouth disease virus and exhibits pro-
teolytic activity (de Felipe, 2004). In this thesis it was used to preserve the endogenous
gene expression, through its ability to cleave itself after translation.
To this end, a fusion protein of FABP4, 2A-peptide, and Cre was generated by replac-
ing the endogenous STOP-codon of FABP4 for the 2A- peptide and Cre sequences (Hees,
n.d.), which leads to expression of FABP4 and Cre in a 1:1 stochiometry from one mRNA
molecule after C-terminal cleavage of the viral 2A-peptide chain (Fig. 3.28).
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Figure 3.28: The 2A- technology allows equivalent expression of FABP4 and Cre.
The cDNA of 2A-peptide and Cre was inserted into the FABP4 gene by replacing the endogenous
STOP-codon in exon 4. A neoR-cassette was inserted for negative selection of ES cell clones. Co-
translational processing by the 2A-peptide allows expression of both, FABP4 and Cre. (adapted
from (Hees, n.d.))
To characterize this novel Cre mouse line, FABP4-2A-Cre mice were crossed with 2 es-
tablished independent mouse models containing loxP-flanked target sequences. In a first
approach FABP4-2A-Cre mice were crossed with mice expressing a dominant-negative
form of FOXO1 upon Cre-mediated recombination (FOXODN, (Belgardt et al. , 2008)).
Secondly, FABP4-2A-Cre mice were crossed with mice exhibiting a loxP-flanked allele of
IL-6Rα gene (IL-6RαFL, (Wunderlich et al. , 2010)).
3.3.1 FABP-4-2A-Cre-mediated recombination in FOXODNFABP4 mice
To characterize the newly generated FABP4-2A-Cre mice, animals were crossed with
ROSA-FOXODN mice (Belgardt et al. , 2008) to obtain FOXODNFABP4 mice (Fig. 3.29).
Cre-mediated recombination of the loxP-flanked neoR/STOP-cassette leads to the com-
pound expression of FOXODN and eGFP that can be visualized by FACS or immunohis-
tochemistry analysis.
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STOP! FOXODN!FABP4-2A! Cre!
Figure 3.29: Schematic view of crossing FABP4-2A-Cre mice to FOXODN mice to obtain
FOXODNFABP4 mice.
Mice, heterozygous for FABP4-2A-Cre were crossed with mice homozygously expressing a tar-
geted FOXODN allele, which resulted in the generation of FOXODNFABP4 mice.
Moreover, the targeted insertion of the FOXODN construct into the ROSA26 locus al-
lows for examining the FABP4-2A-Cre-mediated excision efficiciency by Southern blot
analysis (Fig. 3.30 A). For this, hybridization of EcoRV digested genomic DNA with
the ROSA26-probe leads to DNA fragments of 11.5 kb for the WT allele, 11.1 kb for the
targeted allele (FL), and of 8.8 kb (∆) when the allele is deleted by Cre-mediated recom-
bination.
To examine FABP4-2A-Cre-mediated recombination of the loxP-flanked neoR/STOP-cassette
by the FABP4-2A-Cre, Southern blot analysis using genomic DNA isolated from numer-
ous organs was performed. Deletion of the loxP-flanked STOP-cassette was detected in
adipocytes, WAT, and BAT of FOXODNFABP4 mice but not in WT mice (Fig. 3.30 B). In or-
der to investigate the specificity of FABP4-2A-Cre, skeletal muscle, brain and WAT were
also monitored. Strikingly, recombination of the loxP-flanked allele was only present in
WAT of FOXODNFABP4 mice (Fig. 3.30 C), but not in skeletal muscle and brain of these
mice (Fig. 3.30 C).
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Figure 3.30: FABP4-2A-Cre-mediated recombination in FOXODNFABP4-Cre mice.
(A) Strategy to detect Cre-mediated recombination in FOXODNFABP4 mice. Hybridization of
EcoRV digested genomic DNA with the ROSA26 probe results in DNA fragments of 11.5 kb (WT),
11.1 kb (FL), and 8.8 kb (∆). (B) Southern Blot analysis of genomic DNA isolated from adipocytes,
WAT, and BAT of WT and FOXODNFABP4 mice using the in (A) mentioned strategy. (C) Southern
Blot analysis of genomic DNA isolated from liver, skeletal muscle, brain, and WAT of WT and
FOXODNFABP4 mice resulted in the in (A) mentioned DNA fragments.
Next, FABP4-2A-Cre-mediated recombination was further investigated by the extent
of eGFP expression using immunohistochemistry analysis. Since eGFP is expressed upon
Cre-mediated recombination, eGFP detection is an appropriate indicator for Cre activity.
This analysis revealed a specific deletion of the loxP-flanked neoR/STOP-cassette and
thereby eGFP expression in WAT of FOXODNFABP4 mice but not in WAT of WT mice
(Fig. 3.31 A, upper panels). Similarly, investigating eGFP expression in BAT revealed
IRES driven eGFP expression in BAT of FOXODNFABP mice but not in BAT of WT mice
(Fig. 3.31 A, lower panels).
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and Cre are expressed in 1:1 ratio, which is expected to allow very efficient deletion in all tissues expressing the 
endogenous gene such as FABP4 in this case. 
 
 
Southern Blot analysis of several tissues including liver, muscle, brain and adipose tissue was 
performed, which revealed efficient deletion of the loxP flanked STOP cassette in adipose 
tissue, but not in the other tissues, indicating that the FABP42ACre mouse line allows for 
adipose tissue specific deletion, but shows no deletion in other tissues, and thus follows the 
endogenous expression pattern of FAB4 (Figure 2). Morever, these data demonstrate that the 
2ACre technology allows knock-in mice, and ongoing experiments are aimed to demonstrate 
if FAB4 expression is changed in any manner by the 2ACre knock-in.  
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Figure 2: Analysis of deletion of the loxP-flanked STOP cassette in FAB42ACre mice 
Mice carrying either both the FAB42ACre and the STOP-GFP cassette or only the STOP-GFP cassette were sacrificed and 
Southern blot analysis for the deletion of the loxP-flanked STOP cassette was performed. The deletion event was only 
detectable in the adipose tissue of the FAB42ACre mice, but not in other tissues or any tissue of control mice. 
 
Lastly, using FACS analysis, we demonstrated that close to 100% of macrophages from 
FAB42aCre-STOPGFP mice show GFP expression, which is again in accordance with the 
previously found expression of FAB4 in macrophages (Figure 3).  
 
 
 
Figure 3: GFP expression as an indicator of FAB42ACre-mediated deletion in macrophages 
FACS analysis was performed with peritoneal macrophages from control or FAB4-2A-Cre mice also 
heterozygous for the STOP GFP allele. GFP was detectable in more than 90% of all macrophages from the 
FAB4-2ACre mice. 
 
Taken together, we have successfully generated a novel adipocyte and macrophages specific 
Cre line with uses the endogenous promoter but does not disrupt endogenous expression of 
the targeted gene. In case our efforts to generate the Adiponectin-Cre BAC mouse line or the 
Adiponectin2ACre mouse line are fruitless, we will likely instead use the FABP4-Cre line for 
deletion of target genes in the adipose tissue. In case we have to distinguish between an 
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Figure 3.31: GFP expression in adipose tissue and macrophages of FOXODNFABP4 mice.
(A) Immunohistochemistry analysis using anti-GFP antibodies was performed with WAT and
BAT from WT and FOXODNFABP4 mice. (B) FACS analysis to reveal GFP fluorescence was per-
formed with primary peritoneal macrophages (upper panel) and Kupffer Cells (lower panel) from
WT and FOXODNFABP4 mice.
The recombination event in FOXODNFABP4 mice was additionally investigated in pri-
mary peritoneal macrophages and liver resident Kupffer cells, since the expression of
FABP4 is not restricted to adipose tissue alone (Makowski et al. , 2001). FACS analy-
sis revealed a 95 % deletion of the loxP- flanked STOP-cassette in primary peritoneal
macrophages of FOXODNFABP4 mice, indicated by GFP fluorescence (Fig. 3.31 B, upper
panel). Consistent with an almost complete recombination in peritoneal macrophages,
also in Kupffer cells of FOXODNFABP4 mice, GFP fluorescence was detectable. However,
the recombination efficiency, indicated by the amount of GFP fluorescence, was verified
in only 15 % of the Kupffer cells in FOXODNFABP4 mice (Fig. 3.31 B, lower panel).
Taken together, a transgenic mouse was characterized expressing the Cre recombinase
under the control of the FABP4 promotor. It was shown that the FABP4-2A-Cre is func-
tional and its activity reflects the expression pattern of FABP4.
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3.3.2 FABP4-2A-Cre-mediated recombination in IL-6RαFABP4 mice
Recombination by the newly generated FABP4-2A-Cre mouse and its specificity was
demonstrated using the FOXODN mouse mutant.
To confirm these findings, recombination of FABP4-2A-Cre mice was also investigated in
a different control mouse line. JNK-1 was shown to be required for exercise-induced IL-
6 activation. Here, Cre-mediated recombination would selectively inactivate one allele
of the IL-6Rα gene. To this end, FABP4-2A-Cre mice were crossed with mice exhibiting
loxP-flanked alleles of the IL-6Rα gene (IL-6RαFL/FL, (Wunderlich et al. , 2010)) to obtain
IL-6RαFABP4 mice (Fig. 3.32).
FABP4-2A! Cre! IL-6R!"
Figure 3.32: Schematic view of crossing FABP4-2A-Cre mice to IL-6RαFL/FL mice to obtain IL-
6RαFABP4 mice.
Mice, heterozygous for FABP4-2A-Cre were crossed with mice homozygous for a loxP-flanked
IL-6Rα gene, which served as a control to test the functionality of the newly generated FABP4-
2A-Cre.
Efficient deletion of the loxP-flanked exons 2 and 3 and thereby the activity of the
newly generated Cre was proven in Southern blot analysis. Hybridization of BglI di-
gested genomic DNA with the IL-6R probe leads to DNA fragments of 11.5 kb for the
WT allele, 11.1 kb for the targeted allele (FL) and of 6.3 kb for the deleted allele by Cre-
mediated recombination (Fig. 3.33 A).
FABP4-2A-Cre-mediated recombination was observed in WAT and BAT of IL-6RαFABP4
mice but not in WT mice (Fig. 3.33 B). In addition, Cre-mediated recombination was not
detected in liver, skeletal muscle, spleen, and brain of WT mice. However, in IL-6RαFABP
mice, deletion of the loxP-flanked STOP-cassette was also observed in liver, skeletal mus-
cle, spleen, and brain, indicating that the activity of FABP4-2A-Cre in IL-6RαFABP4 mice is
not restricted to adipose tissue (Fig. 3.33 B).
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As the Cre was inherited by the mother in case of FOXODNFABP4, but was inherited by the
father in IL-6RαFABP4 mice, it is possible that recombination by FABP4-2A-Cre underlies
gender- specific effects as it was shown for Keratin-14 Cre mice, in which loxP-flanked
sequences were completely deleted in all tissues when the Cre allele was inherited by the
mother (Hafner et al. , 2004).
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Figure 3.33: FABP4-2A-Cre-mediated recombination in IL-6RαFABP mice.
(A) Strategy to detect Cre-mediated recombination in IL-6RαFABP4 mice. Hybridization of BglI
digested genomic DNA with the IL6R probe results in DNA fragments of 11.5 kb (WT), 11.1 kb
(FL), and 6.3 kb (∆). (B) Southern Blot analysis of genomic DNA isolated from WAT, BAT, liver,
skeletal muscle, spleen, brain, and tail of WT and IL-6RαFABP4 mice using the in (A) mentioned
strategy. Mice are male and female, Cre recombinase was inherited by the father. Note that the
fragment size for WT and FL alleles is almost similar. (C) PCR analysis of genomic DNA isolated
from tail of WT and IL-6RαFABP4 mice using primers to detect recombined alleles of the IL-6Rα
gene and and the appearence of Cre, respectively. PCR analysis lead to DNA fragments of 630 bp
(WT), 600 bp (targeted allele, FL), and 450 bp (deleted allele, ∆). Mice are male and female, Cre
recombinase was inherited by the mother.
To unravel such gender-specific effects, IL-6RαFABP4 mice were generated, in which
the FABP-4-2A-Cre was inherited by the mother. However, PCR analysis from genomic
tail DNA revealed that FABP4-2A-Cre activity leads to deletion of the exons 2 and 3 of
the IL-6Rα gene in tail tissue (Fig. 3.33 C). The IL6Rα deletion band is only detectable
in those mice, co-expressing the gene for the FABP4-2A-Cre (Fig. 3.33 C). This indicates
that FABP4-2A-Cre activity leads to recombination of the IL-6Rα gene in all tissues and
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confirms the results obtained from Southern Blot analysis.
Taken together, a transgenic mouse line was characterized expressing the Cre recom-
binase under the control of the FABP4 promotor. Furthermore, the expression of Cre is
similar to endogenous gene expression of FABP4. Thus, the newly generated FABP4-2A-
Cre is a useful addition to the pool of tools for genetic loss or gain of function studies
in myeloid cells and adipose tissue and selectively in adipose tissue after replacing bone
marrow derived cells by WT myeloid cells. However, caution is needed when investigat-
ing FABP4-2A-Cre-mediated recombination in specific loci, such as the IL-6Rα gene.
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Body weight gain and on a longer time scale obesity result from positively shifiting the
equilibrium between energy consumption and energy expenditure. Strikingly, obesity
presents the basis for the development of several metabolic disorders, including insulin
resistance and type 2 diabetes, and in cooperation with physical inactivity obesity is one
of the main causes for premature death.
To develop therapeutical strategies to combat the obesity pandemic it is crucial to gain
mechanistical insights into the molecular regulation of energy homeostasis and its un-
derlying signaling pathways.
The finding that obesity is accompanied with an increased inflammatory tone (Hotamis-
ligil et al. , 1993) has set the ground to unravel the signaling pathways contributing to
the development of obesity-associated insulin resistance. The stress-sensitive kinase JNK
was shown to negatively interfere with insulin signaling via inhibitory serine phospho-
rylation of IRS, and thereby blocking downstream insulin signaling (Aguirre et al. , 2000).
Moreover, obesity-induced ER stress contributes to the activation of JNK, an effect which
is aggravated by the release of pro-inflammatory cytokines, such as TNF-α or IL-6 into
the circulation.
To directly address the role of skeletal muscle-derived JNK-1 in the regulation of insulin
signaling, JNK-1 was conditionally ablated in the skeletal muscle and animals were ana-
lyzed in terms of energy and glucose homeostasis.
4.1 Role of skeletal muscle specific JNK-1 in metabolic
regulation
4.1.1 Inactivation of the JNK-1 gene specifically in skeletal muscle
The JNK protein family comprises three members, namely JNK-1, JNK-2, and JNK-3
(Davis, 2000). While the metabolic role of JNK-2 and JNK-3 remain to be elucidated, the
JNK-1 protein isoform was found to possess a central role in the regulation of obesity-
associated insulin resistance (Hirosumi et al. , 2002). Previous experiments revealed that
84
4 Discussion
conventional JNK-1 knockout mice (JNK-1∆) exhibit decreased body weight gain in diet-
induced obesity and concomitantly display strongly improved glucose tolerance and in-
sulin sensitivity. However due to the nature of the JNK-1 construct used in this study,
the authors were unable to address the metabolic tissue in which the activity of JNK-1 is
contributing to the development of obesity-associated insulin resistance.
Here, mice were generated with a conditional inactivation of the JNK-1 gene in skeletal
muscle (JNK-1SM-KO mice). A conditional disruption of loxP-flanked allele in the skeletal
muscle was first described in 1998 by using a mouse line expressing the Cre recombinase
from the promotor of muscle creatine kinase (MCK) (Brüning et al. , 1998). The expres-
sion of MCK is restricted to skeletal muscle and heart and the maximum of expression is
achieved ten days after birth (Brüning et al. , 1998). MCK-Cre-mediated recombination of
the loxP-flanked exon 2 of the JNK-1 gene results in the total absence of JNK-1 protein in
skeletal muscle of JNK-1SM-KO mice, whereas JNK-1 expression in the liver of JNK-1SM-KO
mice was comparable to WT mice. Moreover, JNK-1SM-KO mice were vital and displayed
no apparent abnormalities compared to WT mice. Taken together, mice with a skeletal
muscle specific deficiency of JNK-1 represent a reliable model to analyze the role of JNK-1
in this tissue in vivo.
4.1.2 Role of skeletal muscle specific JNK-1 in the regulation of energy and
glucose homeostasis
Obesity leads to JNK activation in numerous metabolic tissues (Hirosumi et al. , 2002).
Importantly, JNK activity increased in skeletal muscle of WT mice after 17 weeks of HFD-
feeding that furthermore resulted in obesity and increased adiposity of WT mice, which
was accompanied by increased circulating levels of leptin, insulin, and glucose. These
data revealed that feeding a HFD is an appropriate model to study the development of
obesity.
However, a skeletal muscle specific JNK-1 deficiency did not ameliorate the degree of
adiposity. Since JNK-1SM-KO mice displayed no alterations in body composition when
compared to WT mice, also the rate of energy expenditure, indicated by O2 consumption
and CO2 production, remained unaltered between the genotypes.
Taken together, these data demonstrate that the protective effects obeserved in JNK-1∆
mice (Hirosumi et al. , 2002), not originate from the activity of JNK-1 in skeletal muscle,
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and that JNK-1 activity in other metabolic tissues than skeletal muscle accounts for these
improvements.
However, Sabio and colleagues proposed skeletal muscle derived JNK-1 to contribute
to the systemic insulin resistance observed in WT mice upon HFD feeding (Sabio et al.
, 2010), an effect which was further supported by the finding of an enhanced insulin-
stimulated glucose uptake in skeletal muscle upon HFD in these mice when compared to
WT mice (Sabio et al. , 2010).
In contrast, the data presented in this thesis could not confirm the described role of skele-
tal muscle derived JNK-1 to contribute to local and systemic insulin resistance. Feeding
a HFD resulted in the development of insulin resistance in both, WT and JNK-1SM-KO
mice, and the absence of JNK-1 in skeletal muscle in the present work did not result in
improved insulin signaling. Furthermore JNK-1SM-KO mice did not show alterations in
glucose homeostasis.
Taken together, the data of the present thesis demonstrate that lacking JNK-1 in skeletal
muscle does not contribute to enhanced insulin sensitivity or an improved glucose home-
ostasis as observed in conventional JNK-1 knockout mice (Hirosumi et al. , 2002).
The controversial outcome of this study and the study of Sabio and colleagues cannot be
explained. Sabio and colleagues assumed that an increased inflammation status of the
adipose tissue in mice lacking JNK-1 in skeletal muscle could additionally contribute to
the systemic insulin resistance in those mice (Sabio et al. , 2010).
However, the differences in data presented here to the previously described role for skele-
tal muscle specific JNK-1 by Sabio and colleagues are only minor, and also in the latter
study skeletal muscle derived JNK-1 did not contribute to the development of obesity
(Sabio et al. , 2010).
Moreover, analysis of mice lacking JNK-1 in the liver or in the adipose tissue revealed
that JNK-1 in none of those tissues contributed to the development of obesity-associated
insulin resistance (Sabio et al. , 2008, 2009) that was improved in mice with complete in
JNK-1-deficiency (Hirosumi et al. , 2002). JNK-1 in adipose tissue is associated with the
development of hepatic insulin resistance (Sabio et al. , 2008) that was not reflected in
mice lacking JNK-1 in the liver as these mice show the same status of insulin sensitivity
as WT mice (Sabio et al. , 2009). Interestingly, mice with an ablation of JNK-1 signaling
in the adipose tissue showed reduced circulation levels of the pro-inflammatory cytokine
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IL-6, and hence a reduction in SOCS3-mediated hepatic insulin resistance in diet induced
obesity (Sabio et al. , 2008). Though this finding revealed a crosstalk between adipose
tissue-derived JNK-1 and hepatic insulin sensitivity through JNK-1 mediated increases
of systemic IL-6, the adipose tissue cannot be the tissue that is affected by JNK-1 defi-
ciency to result in resistance to diet induced obesity.
Interestingly, a central inactivation of JNK-1 using the Nestin-Cre line results in a de-
creased body weight gain in both NCD and HFD (Belgardt et al. , 2010a), an effect which
is comparable occurring in mice with a whole body ablation of JNK-1 (Hirosumi et al. ,
2002). However, absence of JNK-1 in Nestin-expressing cells does not lead to alterations
in levels of adiposity, but reduced length was observed in these mice. This indicates that
the observed reduction in body weight gain in those mice might result from a decrease in
naso-anal length, which develops as a consquence of a decreased activation of the soma-
totrophic axis, as revealed by decreased circulating levels of the pituitary derived growth
hormone and insulin-like growth factor (IGF)-1 (Belgardt et al. , 2010a).
However, CNS-specific JNK-1 inactivation also ameliorated diet induced development of
insulin resistance. Nevertheless, improvements in insulin sensitivity and glucose toler-
ance in CNS-deficient JNK-1 mice might be a secondary consequence due to disorders in
the growth axis, and, hence a failure to develop obesity (Belgardt et al. , 2010a). While
these data demonstrate a crucial role for neuron-derived JNK-1 in obesity-associated
pathologies, the exact neuron population mediating this effect has not been defined yet.
Taken together, this thesis (JNK-1SM-KO mice) and studies in mice with a selective deletion
of JNK-1 in adipose tissue (Sabio et al. , 2008), liver (Sabio et al. , 2009), or CNS (Belgardt
et al. , 2010a) could not fully clarify the molecular and tissue specific mechanisms leading
to the decreased adiposity observed in whole body JNK-1 knockout mice (Hirosumi et al.
, 2002).
4.1.3 Role of skeletal muscle specific JNK-1 in the regulation of
exercise-induced IL-6 activation
Exercise was shown to activate JNK in skeletal muscle of humans and rats (Boluyt et al. ,
2003; Goodyear et al. , 1996). However, data for a skeletal muscle specific increase of JNK
activation in mice are still missing.
Here, a significantly increased JNK phosphorylation in skeletal muscle of WT mice was
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observed after 30 and 60 minutes of treadmill running representing a bout of exercise.
Hereto, increased ROS levels due to an elevated oxidative phosphorylation in mitochon-
dria might be a contributing factor (Davies et al. , 1982). In fact, it has been demonstrated
that ROS are able to activate the JNK pathway (Bouloumie et al. , 1999).
In line with previous findings, indicating muscle tissue as an endocrine organ releas-
ing myokines into the circulation (Pedersen & Febbraio, 2008), the results of this thesis
demonstrated increased levels of IL-6 mRNA within the skeletal muscle after 30 minutes
of exercise. Crucially, the production of IL-6 by the skeletal muscle during exercise fulfills
beneficial effects to satisfy the needs of the working muscle, either intrinsically to enhance
glucose uptake and fat oxidation, or systemically to promote hepatic glycogenolysis and
lipolysis (Kelly et al. , 2009).
However, the signaling pathways within the skeletal muscle that increase IL-6 upon exer-
cise stimulation are not understood (Pedersen, 2011). Previously, it has been reported that
the mechanical load upon contraction leads to increased calcium concentrations within
the skeletal muscle, and thus to activation of the calcium-sensitive kinase Calcineurin
leading to increased activity of the transcription factor NFAT (Dolmetsch et al. , 1998).
However, experiments in human muscle biopsies after 60 minutes of concentric exercise
revealed no effect on the nuclear abundance of NFAT but IL-6 mRNA levels were in-
creased (Chan et al., 2004). Moreover, as a result of low glycogen concentrations, the
skeletal muscle elevated IL-6 mRNA expression, through a MAP kinase p38 including
mechanism (Chan et al. , 2004). However, IL-6 expression is quick and starts with the be-
ginning of exercise (Pedersen & Febbraio, 2008). Thus, other signaling pathways might
be responsible for the exercise-dependent increase of IL-6 expression in skeletal muscle.
In immune cells, IL-6 is a classical target gene of the transcription factor family NFκB
(Jimi & Ghosh, 2005). However, in collaboration with the Febbraio group, this thesis
presents evidence that the observed increase in IL-6 mRNA in skeletal muscle of mice
occurs independently of NFκB-regulated transcriptional control (Whitham et al. , 2012).
To ascertain a role for skeletal muscle derived JNK-1 in the exercise dependent regulation
of IL-6, exercise dependent changes were determined in JNK-1SM-KO mice. First, exercise-
dependent changes in the phosphorylation state of IKKβ or the inhibitor IκB were not
observed in both, WT and JNK-1SM-KO mice. Second, Whitham and colleagues mimicked
exercise in C2C12 myotubes by applying electronic pulse stimulation (Whitham et al. ,
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2012). However, upon exercise stimulation C212 mytotubes did not show alterations in
the activation of NFκB but IL-6 levels were highly increased (Whitham et al. , 2012).
It was reported previously that mice lacking JNK-1 in the adipose tissue displayed de-
creased levels of IL-6 mRNA within the adipose tissue that translated to reduced IL-6
levels in circulation (Sabio et al. , 2008). Here, JNK-1SM-KO mice exhibited IL-6 levels com-
parable to that in WT mice under resting conditions. However, when exposed to exercise,
WT mice showed a marked increase of IL-6 mRNA expression in the skeletal muscle that
was blunted in skeletal muscle of JNK-1SM-KO mice, indicating a crucial role JNK-1 in the
regulation of the exercise-dependent activation of IL-6. Together with the finding that
JNK is activated upon exercise, it is tempting that JNK-1 mediated AP1 activation in-
duces IL-6 in the exercised muscle (Fig. 4.1).
The data presented here are consistent with previous findings, revealing an association
between JNK phosphorylation and IL-6 expression in myotubes treated with LPS (Frost
et al. , 2003). Moreover, unchanged total JNK phosphorylation upon exercise in skele-
tal muscle specific JNK-1 deficient mice revealed that the insufficiency to produce IL-6
mRNA in skeletal muscle of JNK-1SM-KO mice is dependent on the JNK-1 protein iso-
form. Additionally, exercise stimulation in myotubes led to a marked increase in JNK
activity, also indicated by increased activity of AP-1 on the IL-6 promotor, and inhibition
of JNK signaling abrogated the effect of an exercise-dependent increase of IL-6 (Whitham
et al. , 2012).
Taken together, these data demonstrate that JNK-1 activity in skeletal muscle is essential
to induce exercise-dependent increases of IL-6. Besides the finding that JNK-1 in skeletal
muscle does not contribute to insulin resistance, the requirement of JNK-1 in the exercise-
dependent induction of IL-6 indicates a beneficial role of JNK-1 in skeletal muscle.
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Figure 4.1: JNK-1 is required for exercise induced IL-6 activation in skeletal muscle.
Physical exercise leads to activation of IL-6 most probably by activation of the JNK-1 signaling
pathway. Exercise induces the activation of JNK-1, which activates its transcription factor AP-1.
AP-1 binds to responsive elements on the IL-6 promotor leading to increase of IL-6 mRNA and
its activation. Exercise-dependent increases in the amount of nitric oxide and calcium within the
muscle cells may only be secondary for IL-6 induction and JNK-1 is the main pathway leading to
exercise dependent IL-6 activation. (adapted from (Belgardt et al. , 2010b))
4.1.4 Constitutive JNK activation in skeletal muscle
The above described data were obtained from mice lacking JNK-1 specifically in skele-
tal muscle. However, as a gain of function approach, parameters of energy and glucose
homeostasis were also addressed in mice constitutively activating JNK-1 in skeletal mus-
cle (JNK-1SM-C). In oder to generate such mice, a fusion protein of JNK-1 and a mutated
version of its upstream kinase MKK7 (MKK7D) was created (Y Wang, 1998). This fu-
sion brings MKK7 and JNK-1 in close proximity that results in constitutive phosphoryla-
tion of JNK-1 by MKK7 independently of any stimuli. The fusion protein of 90 kDa was
specifically expressed in the skeletal muscle of JNK-1SM-C mice by crossing MCK-cre mice
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with ROSA26-JNK-1C mice. The functionality of that construct was verified by enhanced
phosphorylation of the JNK-1 downstream target c-Jun specifically in skeletal muscle.
Therefore, this model of JNK-1 activation is suited to analyze the effects of a HFD-induced
JNK-1 activation specifically in skeletal muscle even without exposing those mice to
HFD.
Parameters of energy homeostasis were assessed upon feeding a NCD in both, WT and
JNK-1SM-C mice. However, JNK-1SM-C mice gained body weight similarly as WT mice.
Moreover, naso-anal length as well as adiposity levels were unchanged between the
genotypes.These data demonstrate that a constitutive activation of JNK-1 in skeletal mus-
cle leaves bodyweight gain and adiposity unaltered.
To assess putative differences in glucose homeostasis between WT and JNK-1SM-C mice,
a glucose or a pyruvate challenge was applied, respectively. While an acute bolus of
glucose did not alter serum glucose levels during the GTT in JNK-1SM-C mice, injecting
pyruvate resulted in increased serum glucose concentrations in JNK-1SM-C mice when
compared to WT mice. During fasting, pyruvate is metabolized back to glucose in the
liver to maintain stable serum glucose levels. Thus, this indicates an enhanced hepatic
glucose production in JNK-1SM-C mice, a finding which is supported by an increased ex-
pression of the gluconeogenesis rate-limiting enzyme PEPCK in the liver of JNK-1SM-C
mice.
Previous observations demonstrated that hepatic glucose production is regulated by IL-6
and insulin (Belgardt et al. , 2010a; Wunderlich et al. , 2010). For instance, mice lacking the
IL-6Rα gene in hepatocytes display not only systemic and hepatic insulin resistance, but
also altered expression of key-enzymes of hepatic glucose production such as glucose-
6-phosphatase and glucokinase (Wunderlich et al., 2010). Moreover, recent experiments
revealed a CNS-specific role of insulin in the regulation of hepatic IL-6 expression that
resulted in alterations of hepatic glucose production (Belgardt et al. , 2010a). Experiments
with obese mice lacking JNK-1 in the CNS revealed a reduced hepatic glucose produc-
tion and a protection from hepatic obesity-induced insulin resistance as a result of de-
creased circulating IL-6 (Belgardt et al. , 2010a). Moreover the insulin sensitive neuronal
cell type that regulates hepatic IL-6 expression was identified as agouti-related peptide
(AgRP)-expressing neurons (Könner et al. , 2007). In this study, mice lacking the insulin
receptor specifically in AgRP neurons displayed reduced insulin-stimulated hepatic IL-
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6 expression and increased hepatic glucose production in euglycemic-hyperinsulinemic
clamp analysis when compared to WT mice (Könner et al. , 2007). Furthermore, it was
shown that IL-6 directly activates the expression of PEPCK in the liver (Banzet et al. ,
2009). Thus, IL-6 regulates hepatic glucose production and could be a cause of enhanced
pyruvate conversion to glucose in JJNK-1SM-C mice.
To directly address expression of IL-6 in JNK-1SM-C mice, IL-6 mRNA expression was
investigated in both, skeletal muscle and liver. While fasted IL-6 mRNA expression
in skeletal muscle was decreased in JNK-1SM-C mice when compared to WT mice, IL-6
mRNA expression in liver was unaltered between the genotypes.
Thus, in the model of JNK-1 activation in skeletal muscle presented here, IL-6 is not re-
sponsible for the elevated hepatic glucose production observed in JNK-1SM-C mice. The
muscle specific factor which is responsible for the impaired hepatic glucose production
JNK-1SM-C mice that links skeletal muscle and liver metabolism, remains unkown and
still has to be identified.
4.1.5 Successful generation of a conditional JNK-2 allele in mice
Previously it was demonstrated that the JNK-1 isoform rather than JNK-2 and JNK3 plays
a critical role in the development of obesity induced insulin resistance (Hirosumi et al. ,
2002). However, compensatory effects of the two other JNK isoforms in JNK-1 knockout
mice cannot be fully excluded. In line with this notion, JNK-2 is able to phosphorylate the
same transcription factors as JNK-1 and both isoforms are co-expressed in every tissue
whereas JNK-3 expression is mainly detectable in the brain and heart. Thus, synergistic
and compensatory activities between the JNK-1 and JNK-2 isoforms cannot be excluded.
To dissect the defined actions of JNK-1 and JNK-2 in metabolic tissues, a conditional JNK-
2 allele had to be generated. Therefore, a targeting vector containing a loxP flanked exon
3 of the JNK-2 gene was obtained from the European Conditional Mouse Mutagenesis
Program (Eucomm) and introduced into the genome of murine embryonic stem cells by
gene targeting. Southern blot analysis revealed 23 homologous recombined ES cell which
corresponds to a recombination efficiency of 12 %. Properly targeted ES cell clones were
used to generate chimeric mice and JNK-2 chimeras were crossed with Flp-deleter mice
(Rodríguez et al. , 2000) to achieve germline transmission of the JNK-2 allele together with
the excision of the FRT-flanked neoR-cassette, that could influence JNK-2 expression.
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To yield homozygous JNK-2FL/FL mice, the germline transmitted offspring was inter-
crossed. Moreover, JNK-2FL/+ mice were crossed to JNK-1FL/FL mice in order to generate
a mouse line which exhibits both conditional alleles for JNK-1 and JNK-2.
In order to analyze the specific inactivation of JNK-2, or a combined loss of JNK-1 and
JNK-2, these mice can now be crossed with mice expressing Cre in a specific tissue or cell
type (Kühn et al. , 1995). The conventional combined loss of JNK-1 and JNK-2 was shown
to result in embryonic lethality, further supporting the importance of a conditional JNK-2
allele (Sabapathy et al. , 1999).
Taken together, a conditional JNK-2 allele was successfully generated and the newly cre-
ated JNK-2FL mice can be used to further investigate JNK signaling in the control of en-
ergy and glucose homeostasis in tissues that express the Cre recombinase.
4.2 Conditional overexpression of mXBP1s protein in brain and
liver
Obesity is associated with elevated levels of ER stress, which leads to the activation of
the UPR (Hotamisligil, 2010). A main pathway of the UPR is the IRE1/XBP1 pathway.
Upon activation of IRE1 the endoribonuclease activity cleaves inactive XBP1u mRNA to
yield transcriptionally active XBP1s mRNA, which results in the protein expression of the
XBP1s transcription factor. XBP1s translocates into the nucleus and induces target gene
expression of chaperones to compensate the amount of stress on the ER (Glimcher, 2010).
To mimic ER stress genetically, mice were generated that contain the active form XBP1s
in the ROSA26 locus whose expression is prevented by a loxP-flanked STOP cassette. For
this, the SERCA vector containing mXBP1s was generated (Klisch, 2006) and introduced
into the genome of murine ES cells. 24 homologous recombined clones were detected by
Southern blot analysis, which corresponds to an recombination efficiency of 25 %. Cor-
rectly targeted clones were used to generate the ROSA-mXBP1s mouse line.
Subsequently, mXBP1s germline transmitted ROSA-mXBP1s mice were crossed to CAMKII-
Cre (Casanova et al. , 2001) (mXBP1sCamKII), and ALFP-Cre (Kellendonk et al. , 2000) mice
(mXBP1sAlfp), respectively. CAMKII is expressed in all brain regions, however the most
reliable expression was observed in the hippocampus (Casanova et al. , 2001). Therefore,
expression analysis of mXBP1sCamKII mice was conducted in the hippocampus revealing
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increased XBP1s mRNA expression accompanied with enhanced mRNA expression of
the XBP1s downstream target ERdj4 in the hippocampus of mXBP1sCamKII mice. More-
over, the functionality of mXBP1sCamKII mice was also revealed by enhanced mRNA ex-
pression of the ER chaperone GRP78.
Surprisingly, however, hepatic CHOP mRNA expression in mXBP1sCamKII mice was sig-
nificantly increased similarly as in mXBP1sAlfp mice indicating a crosstalk between the
CNS and the liver in ER stress induced gene expression, while ER stress markers in skele-
tal muscle were unaffected in mXBP1sCamKII mice.
Moreover, hepatic GRP78 mRNA expression was also increased in mXBP1sCamKII mice,
though the values did not reach statistical significance. In line with this experiment, gene
expression analysis in liver of mXBP1sAlfp mice revealed increased mRNA and protein
expression of XBP1s that not only increased mRNA expression of its downstream target
ERdj4 but also of CHOP, GRP78, and ATF6 that were significantly upregulated in the liv-
ers of mXBP1sAlfp mice.
Thus, these data not only demonstrate that mXBP1s mice are a valuable tool to charac-
terize the consequences of ER stress induced gene expression, but also hint to a possi-
ble crosstalk between central and hepatic ER stress. The mechanism how such crosstalk
could function is unclear, however could involve a soluble factor that is induced through
central ER stress that subsequently acts systemically especially on the liver. Moreover,
sympathetic or parasympathetic efference could also account for the observed phenomenon
that might regulate liver innervation through the induction of central ER stress. However
at this point of analysis, the aforementioned mechansisms still have to be experimentally
addressed and are therefore speculative.
In collaboration with the Dillin laboratory, the consequences of central ER stress induced
crosstalk to liver ER stress in mXBP1sCamKII mice will be addressed in future studies.
These collaborators generated precedent data in Caenorhabditis elegans revealing that neu-
ronal ER stress induced ER stress in the worms gut (A. Dillin and J. Brüning, personal
communications).
Thus, to reveal whether this mechanism also is present in mammals, the mXBP1sCamKII
mice should be useful to clarify this notion though it might be possible that the neuronal
population that is responsible for the crosstalk between brain and liver may not affected
in those mice. CamKII Cre mice excise loxP-flanked target sequences mainly in neurons
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of the hippocampus but also in parts of the cortex but nevertheless not in all neurons. A
possible other useful Cre line to address this issue might be the Nestin-Cre mouse that
expresses the Cre recombinase in neuronal precursors and thus in all neurons. Further
analysis by the Dillin laboratory will reveal the phenotypical consequences of neuronal
ER stress on mouse physiology and clarify the mechanisms that are used to transmit ER
stress between brain and liver. In line with this notion, the hepatic ablation of XBP1 re-
sults in improved insulin sensitivity accompanied by improved suppression of hepatic
glucose production (Jurczak et al. , 2012). However, brain-deficient XBP1 mice exhibit in-
creased levels of ER stress and their analysis revealed a link between the induction of ER
stress and leptin resistance, a finding which is accompanied by increased food intake and
body weight gain in these mice (Ozcan et al. , 2009). Moreover, a beneficial and protective
effect for ER stress was indicated by its exercise-induced activation in the brain, resulting
in amelioration of neurodegenerative disorders (Kim et al. , 2010).
Taken together, the newly developed ROSA-mXBP1s mice comprise an appropriate tool
to investigate the underlying signaling mechanisms of ER stress, especially in obesity and
obesity-induced insulin resistance.
4.3 FABP4-2A-Cre-mediated recombination
The adipose tissue possess a central role in metabolism by serving not only as organ for
excessive energy storage but also functions as an endocrine organ releasing hormones,
that are termed adipokines (Ferris & Crowther, 2011). These adipokines, e.g. leptin,
adiponectin and others, fulfill major functions in physiology and may contribute to the
state of insulin resistance under obese conditions. Gene targeting strategies involving
site-specific recombinases haven been described to gain insights into the function of adi-
pose tissue specific gene expression.
Here, an adipose tissue-specific Cre mouse strain was characterized, expressing the Cre
recombinase under the control of the endogenous FABP4-promotor. FABP4 (also termed
aP2) is a 15 kDa adipocyte-specific lipid-chaperone, which facilitates lipid transport within
the cell to specific compartments (Hunt et al. , 1986). As previously mentioned, using this
promotor, several adipose tissue-specific Cre lines have been generated, so far (Abel et al.
, 2001; Barlow et al. , 1997; Blüher et al. , 2002). In all of those approaches the integration of
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the Cre transgenic DNA into the genome might interfere with tissue specific Cre expres-
sion due to random integration into the genome and the variability of copy numbers.
Here, for the first time an adipose tissue-specific Cre was generated by applying the prop-
erties of the foot-and-mouth-virus (FMDV)-derived 2A-technology (de Felipe, 2004). The
2A-technology allows a targeted knock-in into the endogenous gene locus and enables
expression of Cre without interfering with endogenous gene expression, and hence is
superior to IRES-technology in which a second protein is expressed from a second ribo-
somal entry site. This notion is achieved by the generation of one mRNA, that produces
a fusion-protein in which FABP4 is linked to Cre by the 2A-peptide. The 2A-protein is
a small peptide of 18 amino-acids and is needed by the FMDV to process the viral poly-
protein (Halpin et al. , 1999). During translation, 2A induces the so termed “skipping“
of the last peptide bond at the C-terminus of 2A by interacting with the exit tunnel of
ribosome, and the ribosome continues translation after releasing the first protein fused to
2A at its C-terminus (de Felipe, 2004; Donnelly et al. , 2001; Sharma et al. , 2011). Hence,
this process results in equimolar amounts of FABP4 and Cre.
Recently, Engert and colleagues generated a Sox17-2A-iCre, in which Cre expression is
driven by the Sox17 promotor, whose expression is restricted to the developing endo-
derm, and to vascular endothelial cells of the cardiovascular and hematopoietic system
(Engert et al. , 2009). In this approach, the 2A-peptide was derived from the Thosea Ais-
gna virus (Engert et al. , 2009).
Here, the FABP4-2A Cre mouse line was generated by Christoph Hees (Hees, n.d.) by
targeted insertion of 2A and Cre into the endogenous FABP4 STOP-codon. To charac-
terize this mouse strain, FABP4-2A-Cre mice were crossed on the one hand to ROSA26-
FOXODN mice (Belgardt et al. , 2008) that express both FOXODN and eGFP upon Cre
mediated recombination. On the other, FABP4-2A-Cre mice were crossed to IL-6RFL mice
(Wunderlich et al. , 2010) to confirm the excision specificity and efficiency on another
loxP-flanked allele.
Analysis of FOXODNFABP4 mice revealed that FABP4-2A-Cre activity was found in adi-
pose tissue, e.g. in white adipocytes, and white and brown adipose tissue, whereas no
Cre activity was detected in skeletal muscle or brain. Furthermore, GFP expression in
FOXODNFABP4 mice indicated Cre activity in peritoneal macrophages (95 % recombina-
tion frequency) and Kupffer cells (15 % recombination frequency). The Cre activity in
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macrophages in the FABP4-2A-Cre mouse line is consistent with previous studies report-
ing expression of FABP4 also in macrophages (He et al. , 2003).
Thus using the novel FABP42aCre line enables the specific inactivation of loxP-flanked
target genes in WAT, BAT and macrophages. Nonetheless, when only adipose tissue spe-
cific gene inactivation is desired, replacing the myeloid compartment in FABP4-2A-Cre
mice by WT by bone marrow transplantation (Kodama Y, 2009) would enable gene tar-
geting specifically in adipocytes.
Moreover, the FABP4-2A-Cre mice were crossed with IL-6RαFL/FL mice (Wunderlich et al.
, 2010) to verify excision specificity and efficiency on another loxP-flanked target gene.
Strikingly, Cre-mediated recombination was observed in all investigated tissues that reached
100% efficiency, including skeletal muscle and liver indicating that FABP4-2A-Cre is ex-
pressed during early embryogenesis that subsequently leads to excision of the loxP-
flanked exons of the IL-6Rα gene in all following cells that originate from the initial Cre
expressing cell.
However, such a differential outcome in the Cre-mediated recombination of target genes
has been reported previously and might involve whether the Cre transgene transmits
through either the female or male germline. Hafner and colleagues, reported that Keratin14-
Cre-mediated deletion occurs in all tissues when the Cre allele was inherited by the
mother (Hafner et al. , 2004), whereas only keratinocytes express Cre when the Cre al-
lele comes from the father. Therefore, IL-6RαFABP4 mice were investigated side by side in
which the FABP4-2A-Cre allele was inherited by the mother and the father, respectively.
However, independent from which gender the Cre allele was transmitted, always a com-
plete excision of the loxP-flanked exons of the IL-6Rα gene was observed in all tissues
as revealed by Southern blot and PCR analysis. Since FABP4 is not expressed in skeletal
muscle or liver, the FABP4-2A-Cre-mediated recombination has happened early during
development.
Indeed, it was reported that FABP4 is expressed also in non-adipogenic tissues during
embryonic development and Cre expression in those tissues leads to ectopic recombi-
nation (Martens et al. , 2010; Urs et al. , 2006). These data are consistent with findings
that in adult mice FABP4 is expressed only in adipocytes and not in macrophages (He
et al. , 2003), indicating that the observed GFP expression in peritoneal macrophages and
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Kupffer cells remained from FABP4-2A-Cre mediated recombination during embryonic
development.
Nevertheless, FABP4-2A-Cre mediated recombination was found in the adipose tissue
and myeloid cell specific using the FOXODN-ROSA26 reporter mouse. Hence, the re-
combination efficiency of the loxP-flanked IL-6Rα gene must contribute to the ubiqui-
tous deletion observed in IL-6RαFABP4 mice. Vooijs and colleagues highlighted that the
distance between two loxP sites alters recombination frequencies and efficiencies (Vooijs
et al. , 2001). However, the distance between loxP sites was similar (e.g. 2kB) in IL-6RαFL
and ROSA-FOXODN mice, thereby excluding this possibility. Furthermore, differences
in the expression level of the target gene or the local chromatin structure might also con-
tribute to different recombination frequencies between two loxP sites (Vooijs et al. , 2001).
Especially, Vooijs and collegues demonstrated that loxP sites in the ROSA26 locus are less
accessible then loxP sites in the retinoblastoma and Brca2 genes (Vooijs et al. , 2001).
Thus, as here ROSA26- and IL-6RαFL alleles were analyzed with the FABP4-2A-Cre trans-
gene, the aformentioned explanation might also account for FABP4-2A-Cre mice. There-
fore, other loxP-flanked target genes than ROSA26 transgenic lines and the IL-6Rα allele
have to be used to verify the usefulness of the FABP4-2A-Cre mouse line in the WAT spe-
cific analysis of gene functions in mice.
Taken together, the 2A-technology was used for the first time to achieve an adipose tissue
specific expression of the Cre recombinase driven by the FABP4-promotor. However, ex-
pression of FABP4 and hence, Cre activity was also found in peritoneal macrophages and
to a lesser extent in Kupffer cells. Moreover, FABP4 expression is highly complex and is
suggested also in early developmental stages, which may lead to ectopic expression of
Cre that would lead to the complete excision of loxP-flanked target sequences. Notewor-
thy, Cre-mediated recombination depends on the target gene and the location of the loxP
sites that must be taken into account when applying the newly developed FABP4-2A-Cre
to analyze gene functions within the adipose tissue.
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